Aaby, P., Ariyoshi, K., Buckner, M., Jensen, H., Berry, N., Wilkins, A., Richard, D., Larsen, 0., Dias, F., Melbye, M., Whittle, H. (1996). Age of wife as a major determinant of male-to-female transmission ofHIV-2 infection: a community study from rural West Africa. Aids 10, 1585-1590.

Abranches, P., Santos-Gomes, G., Rachamim, N., Campino, L., Schnur, L.F., Jaffe, C.L. (1991). An experimental model for canine visceral leishmaniasis. Parasite Immunol 13,537-550.

Agarwal, A., Ramesh, Ashutosh, Goyal, N., Chauhan, P.M., Gupta, S. (2005). Dihydropyrido[2,3-d]pyrimidines as a new class of antileishmanial agents. Bioorg Med Chern 13, 6678-6684.

Agu, W.E., Farrell, J.P., Soulsby, E.J. (1981). Complement increases in experimental Leishmania donovani infection of the golden hamster.Int J Parasitolll, 133-136.

Ahmed, A.A., Nordlind, K., Schultzberg, M., Liden, S. (1994). Interleukin-l alpha- and beta-, interleukin-6- and tumour necrosis factor-alpha-like immunoreactivities in chronic granulomatous skin conditions. Acta Derm Venereal 74, 435-440.

Aj dary , S., Alimohammadian, M.H., Eslami, M.B., Kemp, K., Kharazmi, A. (2000). Comparison of the immune profile of nonhealing cutaneous Leishmaniasis patients with those with active lesions and those who have recovered from infection. Infect Immun 68, 1760-1764.

Aksoy, N., Ozbilge, H., Keles, S., Iriadam, M., Vural, H., Akcay, F. (2004). A preliminary approach to the separation of Leishmania cell-surface antigens. J Sep Sci 27, 1011-1016.

AI-Abdely, H.M., Graybill, J.R, Bocanegra, R, Najvar, L., Montalbo, E., Regen, S.L., Melby, P.C. (1998). Efficacies of KY62 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous leishmaniasis and visceral leishmaniasis. Antimicrob Agents Chern other 42, 2542-2548.

Al-Taqi, M., Mohammed, A.H. (1981). Susceptibility of Kuwaiti rodents and experimental mice to isolates of Leishmania spp. Trans R Soc Trap Med Hyg 75, 133-136.

Albertini, M., Rehling, P., Erdmann, R, Girzalsky, W., Kiel, J.A., Veenhuis, M., Kunau, W.H. (1997). Pexl4p, a peroxisomal membrane protein binding both receptors of the two PTS-dependent import pathways. Cell 89, 83-92.

Aleshin, A.E., Fromm, H.J., Honzatko, RB. (1998). Multiple crystal forms of hexokinase I: new insights regarding conformational dynamics, subunit interactions, and membrane association. FEBS Lett 434, 42-46.

Alley, M.C., Lieber, M.M. (1984). Improved optical detection of colony enlargement and drug cytotoxicity in primary soft agar cultures of human solid tumour cells. Br J Cancer 49, 225-233. ~

Alley, M.e., Scudiero, D.A., Monks, A., Hursey, M.L., Czerwinski, M.J., Fine, D.L., Abbott, B.J., Mayo, J.G., Shoemaker, RH., Boyd, M.R (1988). Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48, 589-601. ~

Altman, F.P. (1976). Tetrazolium salts and formazans. Prog Histochem Cytochem 9, 1-56.

References

Alvar, J., Molina, R, San Andres, M., Tesouro, M., Nieto, J., Vitutia, M., Gonzalez, F., San Andres, M.D., Boggio, J., Rodriguez, F., et al. (1994). Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy. Ann Trop Med Parasitol88, 371-378.

Alvar, J., Canavate, C., Gutierrez-Solar, B., Jimenez, M., Laguna, F., Lopez-Velez, R, Molina, R., Moreno, J. (1997). Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev 10, 298-319.

Angeby, KA, Klintz, L., Hoffner, S.E. (2002). Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay. J Clin Microbiol40, 553-555.

Anuradha, Pal, R, Zehra, K, Katiyar, J.e., Sethi, N., Bhatia, G., Singh, RK (1992). The Indian langur: preliminary report of a new nonhuman primate host for visceral leishmaniasis. Bull World Health Organ 70, 63-72.

Arevalo, I., Ward, B., Miller, R, Meng, T.e., Najar, E., Alvarez, E., Matlashewski" G., Llanos-Cuentas, A. (2001). Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator. Clin Infect Dis 33, 1847-1851.

Arnot, D.E., Barker, D.C. (1981). Biochemical identification of cutaneous leishmanias by analysis of kinetoplast DNA. II. Sequence homologies in Leishmania kDNA Mol Biochem Paras ito I 3, 47-56.

Ashford, D.A., David, J.R., Freire, M., David, R., Sherlock, I., Eulalio, M.C., Sampaio, D.P., Badaro, R (1998). Studies on control of visceral leishmaniasis: impact of dog control on canine and human visceral leishmaniasis in Jacobina, Bahia, Brazil. Am J Trop Med Hyg 59, 53-57. ~

Ashford, R.W., Desjeux, P., Deraadt, P. (1992). Estimation of population at risk of infection and number of cases of Leishmaniasis. Parasitol Today 8, 104-105. L----­

Ashutosh, Gupta, S., Ramesh, Sundar, S., Goyal, N. (2005). Use of Leishmania donovani field isolates expreSsIng the luciferase reporter ge~n in vitro drug screening. Antimicrob Agents Chemother 49, 3776-3783. ~

Augustyns, K, Amssoms, K, Yamani, A., Rajan, P.K, Haemers, A. (2001). Trypanothione' as a target in the design of antitrypanosomal and antileishmanial agents. Curr Pharm Des 7, 1117-1141.

Austin, D.N., Mikhail, M.G., Chiodini, P.L., Murray-Lyon, I.M. (1999a). Intestinal capillariasis acquired in Egypt. Eur J Gastroenterol Hepatol11, 935-936. ~

Austin, F.W., Corstvet, RE., Schnorr, KL., Todd, W.J. (1992). A characterization of monoclonal antibodies prepared against Pasteurella haemolytica serotype 1 surface antigens. Vet Microbiol32, 327-342. ~

Austin, S.E., Khan, M.O., Douglas, KT. (1999b). Rational drug design using trypanothione reductase as a target for anti-trypanosomal and anti-Ieishmanial drug leads. Drug Des Discov 16, 5-23. V

Avlonitis, N., Lekka, E., Detsi, A, Koufaki, M., Calogeropoulou, T., Scoulica, E., Siapi, E., Kyrikou, I., Mavromoustakos, T., Tsotinis, A., Grdadolnik, S.G., Makriyannis, A. (2003). Antileishmanial ring-substituted ether phospholipids. J Med Chern 46, 755-767.

Awasthi, A., Mathur, RK, Saha, B. (2004). Immune response to Leishmania infection. Indian J Med Res 119,238-258.

Babaloo, Z., Kaye, P.M., Eslami, M.B. (2001). Interleukin-13 in Iranian patients with visceral leishmaniasis: relationship to other Th2 and Thl cytokines. Trans R Soc Trop Med Hyg 95, 85-88.

175

References

Bahamdan, KA, Tallab, T.M., Johargi, H., Nourad, M.M., Ibrahim, K, el Sherbini, A.H., Karkashan, E., Khare, A.K, Nauri, M.M. (1997). Terbinafine in the treatment of cutaneous leishmaniasis: a pilot study. Int J Dermatol36, 59-60.

Baker, C.N., Banerjee, S.H., Tenover, F.C. (1994). Evaluation of Alamar colorimetric MIC method for antimicrobial susceptibility testing of gramnegative bacteria. J Clin Microbiol32, 1261-1267.

Bakker, B.M., Mensonides, F.I., Teusink, B., van Hoek, P., Michels, P.A, Westerhoff, H.V. (2000). Compartmentation protects trypanosomes from the dangerous design of glycolysis. Proc Natl Acad Sci USA 97, 2087-2092.

Balana-Fouce, R, Redondo, C.M., Perez-Pertejo, Y., Diaz-Gonzalez, R., Reguera, R.M. (2006). Targeting atypical trypanosomatid DNA topoisomerase I. Drug Discov Today 11, 733-740. \" /

Balanco, J.M., Pral, E.M., da'Silva, S., Bijovsky, AT., Mortara, RA, Alfieri, S.C. (1998). Axenic cultivation and partial characterization of Leishmania braziliensis amastigote-like stages. Parasitology 116 ( Pt 2), 103-113.

Banuls, A.L., Dujardin, J.e., Guerrini, F., De Doncker, S., Jacquet, D., Arevalo, J., Noel, S., Le Ray, D., Tibayrenc, M. (2000). Is Leishmania (Viannia) peruviana a distinct species? A MLEE/RAPD evolutionary genetics answer. J Eukaryot Microbiol 47, 197-207.

Basselin, M., Badet-Denisot, M.A, Lawrence, F., Robert-Gero, M. (1997a). Effects of pentamidine on polyamine level and biosynthesis in wild-type, pentamidine-treated, and pentamidine-resistant Leishmania. Exp Parasitol85, 274-282.

Basselin, M., Lawrence, F., Robert-Gero, M. (1997b). Altered transport properties of pentamidine-resistant Leishmania donovani and L. amazonensis promastigotes. Parasitol Res 83, 413-418.

Basselin, M., Denise, H., Coombs, G.H., Barrett, M.P. (2002). Resistance to pentamidine in Leishmania mexicana involves exclusion of the drug from the mitochondrion. Antimicrob Agents Chemother 46,3731-3738.

Bates, P.A (1994). Complete developmental cycle of Leishmania mexicana in axenic culture. Parasitology 108 (Pt 1), 1-9.

Bates, P.A, Rogers, M.E. (2004). New insights into the developmental biology and transmission mechanisms of Leishmania. Curr Mol Med 4,601-609.

Baum, S.G., Wittner, M., Nadler, J.P., Horwitz, S.B., Dennis, J.E., Schiff, P.B., Tanowitz, RB. (1981). Taxol, a microtubule stabilizing agent, blocks the replication of Trypanosoma cruzi. Proc Natl A cad Sci USA 78, 4571-4575. ~

Bekaert, E.D., Dole, E., Dubois, D.Y., Bouma, M.E., Lontie, J.F., KaBel, R, Malmendier, C.L., Ayrault-Jarrier, M. (1992). Alterations in lipoprotein density classes in infantile visceral leishmaniasis: presence of apolipoprotein SAA Eur J Clin Invest 22, 190-199.

Belkaid, Y., Hoffmann, KF., Mendez, S., Kamhawi, S., Udey, M.C., Wynn, T.A., Sacks, D.L. (2001). The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-I 0 receptor antibody for sterile cure. J Exp Med 194, 1497-1506.

Berhe, N., Wolday, D., Hailu, A., Abraham, Y., Ali, A, Gebre-Michael, T., Desjeux, P., Sonnerborg, A, Akuffo, H., Britton, S. (1999). HIV viral load and response to antileishmanial chemotherapy in co-infected patients. Aids 13, 1921-1925. '..,...

Berhe, N., Hailu, A, Abraham, Y., Tadesse, Y., Breivik, K, Abebe, Y. (2001). Inter-current and nosocomial infections among visceral leishmaniasis patients in Ethiopia: an observational study. Acta Trop 80,87-95. v

176

References

Berman, J.D. (1984a). Leishmania tropica: quantitation of in vitro activity of antileishmanial agents by Giemsa staining, viability, and 3H-formycin B incorporation. J Parasitol70, 561-562.

Berman, J.D. (1984b). Leishmania tropica: quantitation of in vitro activity of antileishmanial agents by Giemsa staining, viability, and 3H-formycin B incorporation. J Parasitol70, 561-562.

Berman, J.D., Waddell, D., Hanson, B.D. (1985). Biochemical mechanisms of the antileishmanial activity of sodium stibogluconate. Antimicrob Agents Chemother 27, 916-920.

Berman, J.D., Gallalee, J.V., Best, J.M. (1987). Biochem Pharmacol36, 197-201. Berman, J.D., Edwards, N., King, M., Grogl, M. (1989). Am J Trop Med Hyg 40, 159-164. Berman, J.D., Badaro, R, Thakur, C.P., Wasunna, K.M., Behbehani, K., Davidson, R,

Kuzoe, F., Pang, L., Weerasuriya, K., Bryceson, A.D. (1998). Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries. Bull World Health Organ 76, 25-32.

Bern, C., Joshi, A.B., Jha, S.N., Das, M.L., Hightower, A., Thakur, G.D., Bista, M.B. (2000). Factors associated with visceral leishmaniasis in Nepal: bed-net use is strongly protective. Am J Trop Med Hyg 63, 184-188.

Bern, C., Hightower, A.W., Chowdhury, R., Ali, M., Amann, J., Wagatsuma, Y., Haque, R, Kurkjian, K., Vaz, L.E., Begum, M., Akter, T., Cetre-Sossah, C.B., Ahluwalia, LB., Dotson, E., Secor, W.E., Breiman, RF., Maguire, J.H. (2005). Risk factors for kala­azar in Bangladesh. Emerg Infect Dis 11, 655-662.

Bern, C., Adler-Moore, J., Berenguer, J., Boelaert, M., den Boer, M., Davidson, RN., Figueras, C., Gradoni, L., Kafetzis, D.A., Ritmeijer, K., Rosenthal, E., Royce, C., Russo, R., Sundar, S., Alvar, J. (2006). Liposomal amphoterici.n_B for the treatment of visceral leishmaniasis. Clin Infect Dis 43, 917-924. \..--'

Berriman, M., Ghedin, E., Hertz-Fowler, C., Blandin, G., Renauld, H., Bartholomeu, D.C., Lennard, NJ., Caler, E., Hamlin, N.E., Haas, B., Bohme, U., Hannick, L., Aslett, M.A., Shallom, J., Marcello, L., Hou, L., Wickstead, B., Alsmark, HC., Arrowsmith, c., Atkin, RJ., Barron, A.J., Bringaud, F., Brooks, K., Carrington" M., Cherevach, I., Chillingworth, TJ., Churcher, c., Clark, L.N., Corton, C.H., Cronin, A., Davies, RM., Doggett, J., Djikeng, A., Feldblyum, T., Field, M.C., Fraser, A., Goodhead, I., Hance, Z., Harper, D., Harris, B.R, Hauser, H., Hostetler, J., Ivens, A., Jagels, K., Johnson, D., Johnson, J., Jones, K., Kerhornou, A.X., Koo, H., Larke, N., Landfear, S., Larkin, C., Leech, V., Line, A., Lord, A., Macleod, A., Mooney, PJ., Moule, S., Martin, D.M., Morgan, G.W., Mungall, K., Norbertczak, H., Ormond, D., Pai, G., Peacock, C.S., Peterson, J., Quail, M.A., Rabbinowitsch, E., Rajandream, M.A., Reitter, C., Salzberg, S.L., Sanders, M., Schobel, S., Sharp, S., Simmonds, M., Simpson, AJ., Tallon, L., Turner, C.M., Tait, A., Tivey, A.R, Van Aken, S., Walker, D., Wanless, D., Wang, S., White, B., White, 0., Whitehead, S., Woodward, J., Wortman, J., Adams, M.D., Embley, T.M., Gull, K., Ullu, E., Barry" J.D., Fairlamb, A.H., Opperdoes, F., Barrell, B.G., Donelson, J.E., Hall, N., Fraser, C.M., Melville, S.E., EI-Sayed, N.M. (2005). The genome of the African trypanosome Trypanosoma brucei. Science 309, 416-422.

Beutler, B., Cerami, A. (1988). Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu Rev Biochem 57, 505-518.

Beveridge, E. (1963). Chemotherapy of leishmaniasis. In: Schnitzer, RJ., Hawking, F (Eds.) Experimental chemotherapy. Academic Press, New York, London 1, 257-280.

177

References

Bhatnagar, S., Guru, P.Y., Katiyar, J.C., Srivastava, R, Mukherjee, A., Akhtar, M.S., Seth, M., Bhaduri, A.P. (1989). Exploration of antileishmanial activity in heterocycles; results of their in vivo & in vitro bioevaluations. Indian J Med Res 89, 439-444.

Bhattacharya, S.K., Sinha, P.K., Sundar, S., Thakur, C.P., Jha, T.K., Pandey, K., Das, V.R., Kumar, N., Lal, C., Verma, N., Singh, V.P., Ranjan, A., Verma, RB., Anders, G., Sindermann, H., Ganguly, N.K. (2007). Phase 4 trial ofmiltefosine for the treatment ofIndian visceral leishmaniasis. J Infect Dis 196,591-598.

Bittencourt, A.L., Barral-Netto, M., (1995). Leishmaniasi~ Doerr W, Seifert G., eds. Tropical Pathology. Berlin: Springer-Verlag. ~

Black, C.M., Beaman, B.L., Donovan, RM., Goldstein, E. (1985). Intracellular acid phosphatase content and ability of different macrophage populations to kill Nocardia asteroides. Infect Immun 47, 375-383.

Black, M.M., Speer, F.D. (1953). Effects of cancer chemotherapeutic agents on dehydrogenase activity of human cancer tissue in vitro. Am J Clin Pathol 25, 218-227.

Blackwell, J.M., Hale, c., Roberts, M.B., Ulczak, O.M., Liew, F.Y., Howard, lG. (1985). An H-ll-linked gene has a parallel effect on Leishmania major and L. donovani infections in mice. Immunogenetics 21, 385-395.

Blattner, J., Helfert, S., Michels, P., Clayton, C. (1998). Compartmentation of phosphoglycerate kinase in Trypanosoma brucei plays a critical role in parasite energy metabolism. Proc Natl Acad Sci USA 95, 11596-11600.

Blazquez, M.A., Lagunas, R, Gancedo, C., Gancedo, J.M. (1993). Trehalose-6-phosphate, a new regulator of yeast glycolysis that inhibits hexokinases. FEBS Lett 329, 51-54.

Blum, J.J. (1993). Intermediary metabolism of Leishmania. Parasitol Today 9, 118-122. Blum, J.1. (1994). Energy metabolism in Leishmania. J Bioenerg Biomembr 26, 147-155. Bodley, A.L., Shapiro, T.A. (1995). Molecular and cytotoxic effects of camptothecin, a

topoisomerase I inhibitor, on trypanosomes and Leishmania. Proc Natl Acad Sci US A 92, 3726-3730.

Boelaert, M., Criel, B., Leeuwenburg, J., Van Damme, W., Le Ray, D., Van der Stuyft, P. (2000). Visceral leishmaniasis control: a public health perspective. Trans R Soc Trop Med Hyg 94,465-471.

Bogdan, C., Rollinghoff, M. (1998). The immune response to Leishmania: mechanisms of parasite control and evasion. Int J Paras ito I 28, 121-134.

Bolognesi, M., Rosano, C., Losso, R, Borassi, A., Rizzi, M., Wittenberg, J.B., Boffi, A., Ascenzi, P. (1999). Cyanide binding to Lucina pectinata hemoglobin I and to sperm whale myoglobin: an x-ray crystallographic study. BiophysJ77, 1093-1099. L­

Bradley, D.J., Kirkley, J. (1972). Variation in susceptibility of mouse strains to Leishmania donovani infection. Trans R Soc Trop Med Hyg 66,527-528.

Bradley, D.J. (1974). Letter: Genetic control of natural resistance to Leishmania donovani. Nature 250,353-354.

Brainard, G.c., Podolin, P.L., Leivy, S.W., Rollag, M.D., Cole, c., Barker, F.M. (1986). Near-ultraviolet radiation suppresses pineal melatonin content. Endocrinology 119, 2201-2205.

Bray, P.G., Barrett, M.P., Ward, S.A., de Koning, H.P. (2003). Pentamidine uptake and resistance in pathogenic protozoa: past, present and future. Trends Parasitol 19, 232-239.

Bray, RS. (1974). Leishmania. Annu Rev Microbiol28, 189-217. Bredius, RG., de Vries, C.E., Troelstra, A., van Alphen, L., Weening, R.S., van de Winkel,

J.G., Out, T.A. (1993). Phagocytosis of Staphylococcus aureus and Haemophilus

178

References

influenzae type B opsonized with polyclonal human IgG 1 and IgG2 antibodies. Functional hFc gamma RIla polymorphism to IgG2. J Immunol151, 1463-1472.

Brown, T.P., Roberts, W., Page, R.K. (1993). Acute hemorrhagic enterocolitis in ratites: isolation of eastern equine encephalomyelitis virus and reproduction of the disease in ostriches and turkey poults. Avian Dis 37,602-605.

Bryceson, A. (1987). Therapy in man. In The leishmaniasis in biology and medicine eds. Peters, W. and Killick-Kendrick, R. London Academic Press, 847-907.

Bryceson, A. (2001). A policy for leishmaniasis with respect to the prevention and control of drug resistance. Trop Med Int Health 6, 928-934.

Bryceson, A.D. (1970). Immunological aspects of clinical leishmaniasis. Proc R Soc Med 63, 1056-1060.

Bryceson, A.D., Bray, R.S., Wolstencroft, R.A., Dumonde, D.C. (1970). Cell mediated immunity in cutaneous leishmaniasis of the guinea-pig. Trans R Soc Trop Med Hyg 64,472.

Buates, S., Matlashewski, G. (1999). Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: efficacy and mode of action. J Infect Dis 179, 1485-1494.

Buckner, F.S., Verlinde, C.L., La Flamme, A.C., Van Voorhis, W.C. (1996). Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase. Antimicrob Agents Chemother 40,2592-2597.

Buhler, D.R. (1962). A simple scintillation counting technique for counting 14C02 in a Warburg flask. Anal Biochem 4, 413.

Bunn-Moreno, M.M., Madeira, E.D., Miller, K., Menezes, lA., Campos-Neto, A. (1985). Hypergammaglobulinaemia in Leishmania donovani infected hamsters: possible association with a polyclonal activator of B cells and with suppression of T cell function. Clin Exp Immunol59, 427-434.

Caceres, AJ., Portillo, R., Acosta, H., Rosales, D., Quinones, W., Avilan, L., Salazar, L., Dubourdieu, M., Michels, P.A., Concepcion, J.L. (2003). Molecular and biochemical characterization of hexokinase from Trypanosoma cruzi. Mol Biochem Parasitol126, 251-262.

Callahan, H.L., Portal, A., Devereaux, R., Grogl, M. (1997). An axenic amastigote system for drug screening. Antimicrob Agents Chemother 41, 818-822.

Cannistra, S.A., Vellenga, E., Groshek, P., Rambaldi, A., Griffin, J.D. (1988). Human granulocyte-monocyte colony-stimulating factor and interleukin 3 stimulate monocyte cytotoxicity through a tumor necrosis factor-dependent mechanism. Blood 71, 672-676.

Cardenas, M.L., Cornish-Bowden, A., Ureta, T. (1998). Evolution and regulatory role of the hexokinases. Biochim Biophys Acta 1401, 242-264.

Carmichael, J., DeGraff, W.G., Gazdar, A.F., Minna, J.D., Mitchell, lB. (1987). Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res 47, 943-946.

Carreras, C.W., Santi, D.V. (1995). The catalytic mechanism and structure ofthymidylate synthase. Annu Rev Biochem 64, 721-762.

Carrio, J., Riera, C., Gallego, M., Ribera, E., Portus, M. (2001). In vitro susceptibility of Leishmania infantum to meglumine antimoniate in isolates from repeated leishmaniasis episodes in HIV-coinfected patients. J Antimicrob Chemother 47, 120-121.

Carswell, E.A., Old, L.J., Kassel, R.L., Green, S., Fiore, N., Williamson, B. (1975). An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72, 3666-3670.

179

References

Carvalho, E.M., Teixeira, R.S., Johnson, W.D., Jr. (1981). Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection. Infect Immun 33, 498-500.

Carvalho, E.M., Johnson, W.D., Barreto, E., Marsden, P.D., Costa, J.L., Reed, S., Rocha, H. (1985). Cell mediated immunity in American cutaneous and mucosal leishmaniasis. J Immunol135, 4144-4148.

Carvalho, E.M., Barral, A., Costa, J.M., Bittencourt, A., Marsden, P. (1994). Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis. Acta Trop 56, 315-325.

Cazzulo, J.J., Franke de Cazzulo, B.M., Engel, J.C., Cannata, J.J. (1985). End products and enzyme levels of aerobic glucose fermentation in trypanosomatids. Mol Biochem Parasitol 16, 329-343.

Cazzulo, J.J. (1992). Aerobic fermentation of glucose by trypanosomatids. F aseb J 6, 3153-3161.

Cerami, A., Beutler, B. (1988). The role of cachectinlTNF in endotoxic shock and cachexia. Immunol Today 9, 28-31.

Cesur, S., Bahar, K, Erekul, S. (2002). Death from cumulative sodium stibogluconate toxicity on Kala-Azar. Clin Microbiol Infect 8, 606. ~ __ // '

Chakraborty, A.K, Majumder, H.K (1988). Biochem Biophys Res Commun 152, 605-611.

Chalfie, M., Tu, Y., Euskirchen, G., Ward, W.W., Prasher, D.C. (1994). Green fluorescent protein as a marker for gene expression. Science 263,802-805.

Champoux, J.J. (2001). DNA topoisomerases: structure, function, and mechanism. Annu Rev Biochem 70, 369-4l3.

Chan, M.M., Bulinski, J.C., Chang, KP., Fong, D. (2003). A microplate assay for Leishmania amazonensis promastigotes expressing multimeric green fluorescent protein. Parasitol Res 89, 266-271. ~

Chandra, N., Pandey, S., Ramesh, Suryawanshi, S.N., Gupta, S. (2006). Chemotherapy of leishmaniasis part III: synthesis and bioevaluation of novel aryl substituted terpenyl pyrimidines as antileishmanial agents. Eur J Med Chem 41, 779-785. V

Chang, C.S., Chang, KP. (1985). Heme requirement and acquisition by extracellular and intracellular stages ofJ.,eishmania mexicana amazonensis. Mol Biochem Parasitol 16, 267-276. ~

Chang, KP., Chaudhuri, G., Fong, D. (1990). Molecular determinants of Leishmania virulence. Annu Rev Microbiol44, 499-529. ~

Chapman, W.L., Jr., Hanson, W.L., Waits, V.B., Kinnamon, KE. (1979). Antileishmanial activity of selected compounds in dogs experimentally infected with Leishmania donovani. Rev Inst Med Trop Sao Paulo 21, 189-193.

Chapman, W.L., Jr., Hanson, W.L. (1981). Visceral leishmaniasis in the squirrel monkey (Saimiri sciurea). J Paras ito I 67, 740-741.

Chapman, W.L., Jr., Hanson, W.L., Hendricks, L.D. (1983). Toxicity and efficacy of the antileishmanial drug meglumine antimoniate in the owl monkey (Aotus trivirgatus). JParasitoI69,1176-1177.

Chappuis, F., Sundar, S., Hailu, A., Ghalib, H., Rijal, S., Peeling, RW., Alvar, J., Boelaert, M. (2007). Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbial 5, 873-882.

Chen, W., Alley, M.R, Manktelow, B.W., Hopcroft, D., Bennett, R (1988). Pneumonia in lambs inoculated with Bordetella parapertussis: bronchoalveolar lavage and ultrastructural studies. Vet Pathol25, 297-303.

180

References

Choe, J., Moyersoen, J., Roach, C., Carter, T.L., Fan, E., Michels, P.A., HoI, W.G. (2003). Analysis of the sequence motifs responsible for the interactions of peroxins 14 and 5, which are involved in glycosotne biogenesis in Trypanosoma brucei. Biochemistry 42, 10915-10922. "v/

Chu, S.c., Marks-Konczalik, J., Wu, H.P., Banks, T.C., Moss, J. (1998). Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human apd mouse iNOS promoters. Biochem Biophys Res Commun 248,871-878. \/

Chudzik, D.M., Michels, P.A., de Walque, S., HoI, W.G. (2000). Structures of type 2 peroxi~..targeting signals in two trypanosomatid aldolases. J Mol Bioi 300" 697-707.

Chulay, J.D., Bhatt, S.M., Muigai, R., Ho, M., Gachihi, G., Were, J.B., Chunge, C., Bryceson, A.D. (1983). A comparison of three dosage regimens of sodium stibogluconate in the..-treatment of visceral leishmaniasis in Kenya. J Infect Dis 148, 148-155. ~

Chulay, J.D., Spencer, H.C., Mugambi, M. (1985). Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate). Am J Trop Med Hyg 34, 702-709. ~

Chunge, C.N., Gachihi, G., Muigai, R, Wasunna, K., Rashid, J.R., Chulay, J.D., Anabwani, G., Oster, C.N., Bryceson, A.D. (1985). Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol. Trans R Soc Trop Med Hyg 79, 715-718.

Chunge, C.N., Owate, J., Pamba, H.O., Donno, L. (1990). Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate. Trans R Soc Trop Med Hyg 84, 221-225.

Clayton, C., Hausler, T., Blattner, J. (1995). Protein trafficking in kinetoplastid protozoa. Microbiol Rev 59, 325-344.

Clayton, C.E. (1985). Structure and regulated expression of genes encoding fructose biphosphate aldolase in Trypanosoma brucei. Embo J 4,2997-3003.

Clayton, c.E., Michels, P. (1996). Metabolic compartmentation in African trypanosomes. Parasitol Today 12, 465-471.

Coelho, A.C., Beverley, S.M., Cotrim, P.C. (2003). Functional genetic identification of PRPl, an ABC transporter superfamily member conferring pentamidine resistance in Leishmania major. Mol Biochem Parasitol130, 83-90.

Coley, W.B. (1893). II. Hawkins on Tubercular Peritonitis. Ann Surg 17, 462-464. Collin, S.M., Coleman, P.G., Ritmeijer, K., Davidson, R.N. (2006). Unseen Kala-azar

deaths in south Sudan (1999-2002). Trop Med Int Health 11, 509-512. Collins, L.A., Torrero, M.N., Franzblau, S.G. (1998). Green fluorescent protein reporter

microplate assay for high-throughput screening of compounds against Mycobacterium tuberculosis. Antimicrob Agents Chemother 42, 344-347.

Convit, J., Ulrich, M. (1993). Antigen-specific immunodeficiency and its relation to the spectrum of American cutaneous leishmaniasis. Bioi Res 26, 159-166.

Cook, G.C. (1990). 'Exotic' parasitic infections: recent progress in diagnosis and management. J Infect 20, 95-102.

Coombs, G.H., Craft, J.A., Hart, D.T. (1982). A comparative study of Leishmania mexicana amastigotes and promastigotes. Enzyme activities and subcellular locations. Mol Biochem Parasitol5, 199-211. \/~

Coombs, G.H., Baxter, 1. (1984). Inhibition of Leishmania amastigote growth by antipain and leupeptin. Ann Trop Med Parasitol78, 21-24. \~

181

References

Corbett, K.D., Berger, J.M. (2004). Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases. Annu Rev Biophys Biomol Struct 33, 95-118.

Costa, C.H., Pereira, H.F., Araujo, M.V. (1990). [Visceral leishmaniasis epid~mic in the State ofPiaui, Brazil, 1980-1986]. Rev Saude Publica 24,361-372. v-,·

Croft, S.L. (1986). In vitro screens in the experimental chemotherapy of leishmaniasis and trypanosomiasis. Parasitol Today 2,64-69.

Croft, S.L., Coombs, G.H. (2003). Leishmaniasis--current chemotherapy and recent advances in the search for novel drugs. Trends Parasitol19, 502-508.

Croft, S.L., Seifert, K., Duchene, M. (20Q3). Antiprotozoal activities of phospholipid analogues. Mol Biochem Parasitol126, 165-172.

Croft, S.L., Sundar, S., Fairlamb, A.H. (2006). Drug resistance in leishmaniasis. Clin Microbiol Rev 19, 111-126.

Cubitt, A.B., Heim, R, Adams, S.R, Boyd, A.E., Gross, L.A., Tsien, R.Y. (1995). Understanding, improving and using green fluorescent proteins. Trends Biochem Sci 20,448-455.

Cupolillo, E., Aguiar Alves, F., Brahim, L.R., Naiff, M.F., Pereira, L.O., Oliveira-Neto, M.P., Falqueto, A., Grimaldi, G., Jr. (2001). Recent advances in the taxonomy of the New World leishmanial parasites. Med Microbiol Immunol190, 57-60.

Cupolillo, E., Brahim, L.R, Toaldo, C.B., de Oliveira-Neto, M.P., de Brito, M.E., Falqueto, A., de Farias Naiff, M., Grimaldi, G., Jr. (2003). Genetic polymorphism and molecular epidemiology of Leishmania (Viannia) braziliensis from different hosts and geographic areas in Brazil. J Clin Microbiol41, 3126-3132.

Dammai, V., Subramani, S. (2001). The human peroxisomal targeting signal receptor, Pex5p, is translocate~ the peroxisomal matrix and recycled to the cytosol. Cell 105, 187-196. ~

Davey, RT., Jr., Chaitt, D.G., Piscitelli, S.c., Wells, M., Kovacs, J.A., Walker, RE., Falloon, J., Polis, M.A., Metcalf, lA., Masur, H., Fyfe, G., Lane, H.C. (1997). Subcutaneous administration of interleukin-2 in human immunodeficiency virus type I-infected persons. J Infect Dis 175, 781-789.

Davies, C.R, Kaye, P., Croft, S.L., Sundar, S. (2003). Leishmaniasis: new approaches to disease control. Bmj 326, 377-382.

Davies, J., Wright, G.D. (1997). Bacterial resistance to aminoglycoside antibiotics. Trends Microbiol5, 234-240.

Davis, G.L., Balart, L.A., Schiff, E.R, Lindsay, K., Bodenheimer, H.C., Jr., Perrillo, RP., Carey, W., Jacobson, I.M., Payne, J., Dienstag, J.L., et al. (1989). Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. Hepatitis Interventional Therapy Group. N Engl J Med 321, 1501-1506.

De Fries, R, Mitsuhashi, M., (1995). Quantification of mitogen induced human lymphocyte proliferation: comparison of alamarBlue assay to 3Hthymidine incorporation assay. J Clin Lab Anal 9, 89-95.

de Ibarra, A.A., Howard, J.G., Snary, D. (1982). Monoclonal antibodies to Leishmania tropica major: specificities and antigen location. Parasitology 85 (Pt 3), 523-531.

de Oliveira, C.I., Teixeira, M.J., Gomes, R, Barral, A., Brodskyn, C. (2004). Animal models for infectious diseases caused by parasites: Leishmaniasis. Drug Discovery Today: Disease Models 1, 81-86.

De Souza, W. (2002). From the cell biology to the development of new chemotherapeutic approaches against trypanosomatids: dreams and reality. Kinetoplastid Bioi Dis 1, 3.

182

References

De Titto, E.H., Catterall, J.R., Remington, J.S. (1986). Activity of recombinant tumor necrosis factor on Toxoplasma gondii and Trypanosoma cruzi. J Immunol 137, 1342-1345.

de Walque, S., Kiel, J.A., Veenhuis, M., Opperdoes, F.R., Michels, P.A. (1999). Cloning and analysis of the /PTS-l receptor in Trypanosoma brucei. Mol Biochem Parasitol 104,106-119. V

Dea-Ayuela, M.A., Rama-Iniguez, S., Alunda, J.M., Bolas-Fernandez, F. (2007). Setting new immunobiological parameters in the hamster model of visceral leishmaniasis for in vivo testing of antileishmanial compounds. Vet Res Commun 31, 703-717.

Debrabant, A., Ghedin, E., Dwyer, D.M. (2000). Dissection of the functional domains of the Leishmania surface membrane 3'-nucleotidase/nuclease, a unique member of the class I nuclease family. J Bioi Chem 275, 16366-16372.

Dennis, V.A., Chapman, W.L., Jr., Hanson, W.L., Lujan, R. (1985). Leishmania donovani: clinical, hematologic and hepatic changes in squirrel monkeys (Saimiri sciureus). J Parasitol71, 576-582. ~

Dennis, V.A., Lujan, R., Chapman, W.L., Jr., Hanson, W.L. (1986). Leishmania donovani: cellular and humoral immune responses after primary and challenge .infections in squirrel monkeys, Saimiri sciureus. Exp Parasitol61, 319-334. ~

Dereure, J., Rioux, J.A., Gallego, M., Perieres, J., Pratlong, F., Mahjour, J., Saddiki, H. (1991a). Leishmania tropica in Morocco: infection in dogs. Trans R Soc Trop Med Hyg85,595.

Dereure, J., Rioux, J.A., Khiami, A., Pratlong, F., Perieres, J., Martini, A. (1991b). [Ecoepidemiology of leishmaniases in Syria. 2--Presence, in dogs, of Leishmania infantum Nicolle and Leishmania tropica (Wright) (Kinetoplastida­Trypanonomatidae)]. Ann Parasitol Hum Comp 66, 252-255.

Desjeux, P. (2001). The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg 95,239-243.

Desjeux, P. (2004). Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27, 305-318.

Dhandayuthapani, S., Via, L.E., Thomas, c.A., Horowitz, P.M., Deretic, D., Deretic, V. (1995). Green fluorescent protein as a marker for gene expression and cell biology of mycobacterial interactions with macrophages. Mol Microbiol17, 901-912.

Di Giorgio, C., Faraut-Gambarelli, F., Imbert, A., Minodier, P., Gasquet, M., Dumon, H. (1999). Flow cytometric assessment of amphotericin B susceptibility in Leishmania infantum isolates from patients with visceral leishmaniasis. J Antimicrob Chemother 44,71-76.

Dietze, R., Carvalho, S.F., Valli, L.C., Berman, J., Brewer, T., Milhous, W., Sanchez, J., Schuster, B., Grogl, M. (2001). Phase 2 trial of WR6026, an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi. Am J Trop Med Hyg 65,685-689.

Ding, A.H., Nathan, C.F., Stuehr, D.J. (1988). Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokitfes and evidence for independent production. J Immunol 141, 2407-2412. v,./

Ding, A.H., Porteu, F., Sanchez, E., Nathan, C.F. (1990). Downregulation of tumor necrosis factor receptors on macrophages and endothelial cells by microtubule depolymerizing agents. J Exp Med 171, 715-727. \....--/'

Drapier, J.C., Wietzerbin, J., Hibbs, J.B., Jr. (1988). Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. EurJ Immunol18, 1587-1592. \.//

183

References

Dube, A., Singh, N., Sundar, S., Singh, N. (2005). Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models. Parasitol Res 96, 216-223.

Durand, R., Paul, M., Pratlong, F., Rivollet, D., Dubreuil-Lemaire, M.L., Houin, R., Astier, A., Deniau, M. (1998). Leishmania infantum: lack of parasite resistance to amphotericin B in a clinically resistant visceral leishmaniasis. Antimicrob Agents Chemother 42, 2141-2143.

Dwivedi, S.N., Guru, P.y', Bhagat, RC., Shankhdhar, V., Sen, A.B. (1983). Comparative susceptibility ofMastomys natalensis and golden hamsters (Mesocricetus auratus) to Leishmania donovani (Abstract). Proc V Natn Cong Paras it 99.

Dye, C. (1992). Leishmaniasis epidemiology: the theory catches up. Parasitology 104 Suppl, S7-18.

EI-Sayed, N.M., Myler, P.J., Blandin, G., Berriman, M., Crabtree, J., Aggarwal, G., Caler, E., Renauld, H., Worthey, E.A., Hertz-Fowler, C., Ghedin, E., Peacock, C., Bartholomeu, D.C., Haas, BJ., Tran, A.N., Wortman, J.R, Alsmark, U.C., Angiuoli, S., Anupama, A., Badger, J., Bringaud, F., Cadag, E., Carlton, J.M., Cerqueira, G.C., Creasy, T., Deicher, A.L., Djikeng, A., Embley, T.M., Hauser, c., Ivens, A.C., Kummerfeld, S.K., Pereira-Leal, J.B., Nilsson, D., Peterson, J., Salzberg, S.L., Shallom, J., Silva, J.c., Sundaram, J., Westenberger, S., White, 0., Melville, S.E., Donelson, J.E., Andersson, B., Stuart, K.D., Hall, N. (2005). Comparative genomics of trypanosoma tid parasitic protozoa. Science 309,404-409.

Elgersma, Y., Elgersma-Hooisma, M., Wenzel, T., McCaffery, J.M., Farquhar, M.G., Subramani, S. (1998). A mobile PTS2 receptor for peroxisomal protein import in Pichia pastoris. J Cell Bioi 140, 807-820. \/

Elgersma, Y., Tabak, H.F. (1999). Proteins involved in peroxisome biogenesis and functioning. Biochim Biophys Acta 1286, 269-283. 'y .. /

Engelhart, M. (1993). Possible role for cytokines in the treatment of lymphoma. In Hemopoietic Growth Factors and Mononuclear Phagocytes, Ed. R Van Furth, Karger, Basel. 177-186.

Enserink, M. (2000). Infectious diseases. Has leishmaniasis become endemic in the U.S.? Science 290, 1881-1883. ~

Ephros, M., Bitnun, A., Shaked, P., Waldman, E., Zilberstein, D. (1999). Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes. Antimicrob Agents Chemother 43, 278-282.

Erb, RE., Ehlers, M.H. (1950). Resazurin reducing time as an indicator of bovine semen capacity. J Dairy Sci 33, 853-864.

Evans, T.G., Smith, D., Pearson, RD. (1990). Humoral factors and nonspecific immune suppression in Syrian hamsters infected with Leishmania donovani. J Parasitol 76, 212-217.

Evans, T.G., Thai, L., Granger, D.L., Hibbs, J.B., Jr. (1993). Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis. J Immunol151, 907-915.

Fairlamb, A.H., Cerami, A. (1992). Metabolism and functions of trypanothione in the Kinetoplastida. Annu Rev Microbiol46, 695-729.

Fakhfakh, M.A., Fournet, A., Prina, E., Mouscadet, J.F., Franck, X., Hocquemiller, R., Figadere, B. (2003). Synthesis and biological evaluation of substituted quinolines: potential treatment of protozoal and retroviral co-infections. Bioorg Med Chem 11, 50l3-5023.

Farault-Gambarelli, F., Piarroux, R, Deniau, M., Giusiano, B., Marty, P., Michel, G., Faugere, B., Dumon, H., (1997). In vitro and in vivo resistance of Leishmania

184

References

infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. Antimicrobial Agents and Chemotherapy 41,827-830.

Farrell, J.P. (1976). Leishmania donovani: acquired resistance to visceral leishmaniasis in the golden hamster. Exp Paras ito I 40, 89-94.

Fauci, A.S., Rosenberg, S.A., Sherwin, S.A., Dinarello, C.A., Longo, D.L., Lane, H.C. (1987). NIH conference. Immunomodulators in clinical medicine. Ann Intern Med 106,421-433.

Fidler, I.J., Schroit, A.J. (1988). Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self. Biochim Bic:t,hYs Acta 948, 151-173.

Finney, D.J. (1971). Probit Analysis. Cambridge Univ Press 3r Edn. Fournet, A., Ferreira, M.E., Rojas De Arias, A., Torres De Ortiz, S., Fuentes, S., Nakayama,

H., Schinini, A., Hocquemiller, R (1996). In vivo efficacy of oral and intralesional administration of 2-substituted quinolines in experimental treatment of new world cutaneous leishmaniasis caused by Leishmania amazonensis. Antimicrob Agents Chemother 40, 2447-2451.

Fransen, M., Terlecky, S.R, Subramani, S. (1998). Identification of a human PTS 1 receptor docking protein directly required for peroxisomal protein import. Proc Natl Acad Sci USA 95, 8087-8092.

Fuchs, F.D., Moreira, L.B., Pires, C.P., Torres, F.S., Furtado, M.V., Moraes, RS., Wiehe, M., Fuchs, S.C., Lubianca Neto, J.F. (2003). Absence of association between hypertension and epistaxis: a population-based study. Blood Press 12, 145-148.

Fulton, J.D., Joyner, L.P. (1948). Infection by Leishmania donovani in the cotton rat. J Gen MicrobioI2,103-109.

Fumarola, L., Spinelli, R, Brandonisio, O. (2004). In vitro assays for evaluation of drug activity against Leishmania spp. Res Microbiol155, 224-230.

Gagnon, D., Foucher, A., Girard, I., Ouellette, M. (2006). Stage specific gene expression and cellular localization of two isoforms of the serine hydroxymethyltransferase in the protozoan parasite Leishmania. Mol Biochem Parasitol150, 63-71.

Gajwani, B.W., Mehta, A., Saved, B.A., Patel, N.M., Pande, RS. (1967). Kala-azar in Gujarat. J Indian MedAssoc 49,216-218. V

Galbraith, RA., McElrath, M.J. (1988). Heme binding to Leishmania mexicana amazonensis. Mol Biochem Parasitol29, 47-53.

Galland, N., Demeure, F., Hannaert, V., Verplaetse, E., Vertommen, D., Van Der Smissen, P., Courtoy, P.J., Michels, P.A.M. (2007). Characterization of the role of the receptors PEX5 and PEX7 in the import of proteins into glycosomes of Trypanosoma brucei. Biochim Biophys Acta. ARTICLE IN PRESS.

Gantt, K.R, Goldman, T.L., McCormick, M.L., Miller, M.A., Jeronimo, S.M., Nascimento, E.T., Britigan, B.E., Wilson, M.E. (2001). Oxidative responses of human and murin: /" macrophages during phagocytosis of Leishmania chagasi. J Immunol167, 893-901. V

Garcia-Salcedo, J.A., Perez-Morga, D., Gijon, P., Dilbeck, V., Pays, E., Nolan, D.P. (2004). A differential role for actin during the life cycle of Trypanosoma brucei. Embo J 23, 780-789.

Garnham, P.C., Humphrey, J.H. (1969). Problems in leishmaniasis related to immunology. Curr Trop Microbiol Immunol48, 29.

Gavgani, A.S., Hodjati, M.H., Mohite, H., Davies, C.R (2002). Effect of insecticide­impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial. Lancet 360,374-379.

Gay, L.S., Wilson, M.E., Donelson, J.E. (1996). The promoter for the ribosomal RNA genes of Leishmania chagasi. Mol Biochem Parasitol77, 193-200.

185

References

Gazzinelli, R.T., Oswald, I.P., James, S.L., Sher, A. (1992). IL-I0 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J Immunol 148, 1792-1796.

Gebre-Hiwot, A., Tadesse, G., Croft, S.L., Frommel, D. (1992). An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-l. Acta Trop 51, 237-245.

Gebre-Hiwot, A., Frommel, D. (1993). The in-vitro anti-leishmanial activity of inhibitors of ergosterol biosynthesis. J Antimicrob Chemother 32,837-842.

Genaro, 0., de Toledo, V.P., da Costa, c.A., Hermeto, M.V., Afonso, L.C., Mayrink, W. (1996). Vaccine for prophylaxis and immunotherapy, Brazil. Clin Dermatol14, 503-512.

Ghalib, H.W., Piuvezam, M.R., Skeiky, Y.A., Siddig, M., Hashim, F.A., el-Hassan, A.M., Russo, D.M., Reed, S.G. (1993). Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest 92,324-329.

Ghersetich, I., Menchini, G., Teofoli, P., Lotti, T. (1999). Immune response to Leishmania infection in human skin. Clin Dermatol17, 333-338.

Ghose, A.C., Haldar, J.P., Pal, S.C., Mishra, B.P., Mishra, KK (1979). Phytohaemagglutinin-induced lymphocyte transformation test in Indian kala-azar. Trans R Soc Trop Med Hyg 73, 725-726.

Ghose, A.C., Haldar, J.P., Pal, S.C., Mishra, B.P., Mishra, KK (1980). Serological investigations on Indian kala-azar. Clin Exp Immunol 40, 318-326.

Gifawesen, C., Farrell, J.P. (1989). Comparison of T-cell responses in self-limiting versus progressive visceral Leishmania donovani infections in golden hamsters. Infect Immun 57, 3091-3096.

Giri, O.P., Singh, A.N. (1994). Experience with amphotericin B in sodium stibogluconate-­unresponsive cases of visceral Leishmaniasis in north Bihar. J Assoc Physicians India 42,690-691.

Githure, J.I., Shatry, A.M., Tarara, R, Chulay, J.D., Suleman, M.A., Chunge, C.N., Else, J.G. (1986). The suitability of East African primates as animal models of visceral leishmaniasis. Trans R Soc Trop Med Hyg 80,575-576.

Goldstein, E., Bartlema, H.C., van der Ploeg, M., van Duijn, P., van der Stap, J.G., Lippert, W. (1978). Effect of ozone on lysosomal enzymes of alveolar macrophages engaged in phagocytosis and killing of inhaled Staphylococcus aureus. J Infect Dis 138,299-311.V

Goncalves, G.S., Fernandes, A.P., Souza, RC., Cardoso, J.E., de Oliveira-Silva, F., Maciel, F.C., Rabello, A., Ferreira, L.A. (2005). Activity of a paromomycin hydrophilic formulation for topical treatment of infections by Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis. Acta Trop 93, 161-167.

Goodwin, L.G. (1995). Pentostam (sodium stibogluconate); y50-year personal reminiscence. Trans R Soc Trop Med Hyg 89, 339-341.~

Gould, SJ., Subramani, S. (1988). Firefly luciferase as a tool in molecular and cell biology. Anal Biochem 175, 5-13. '

Gould, S.J., Keller, G.A., Hosken, N., Wilkinson, J., Subramani, S. (1989). A conserved tripeptide sorts proteins to peroxisomes. J Cell Bioll08, 1657-1664. V~

Gourley, D.G., Schuttelkopf, A.W., Leonard, G.A., Luba, J., Hardy, L.W., Beverley, S.M., Hunter, W.N. (2001). Pteridine reductase mechanism correlates pterin metabolism with drug resistance in trypanosomatid parasites. Nat Struct Bioi 8, 521-525. \.../

Goyard, S., Segawa, H., Gordon, J., Showalter, M., Duncan, R, Turco, S.J., Beverley, S.M. (2003). An in vitro system for developmental and genetic studies of Leishmania donovani phosphoglycans. Mol Biochem Parasitol130, 31-42.

186

References

Grabstein, K, Mochizuki, D., Kronheim, S., Price, V., Cosman, D., Urdal, D., Gillis, S., Conlon, P. (1986). Regulation of antibody production in vitro by granulocyte­macrophage colony stimulating factor. J Mol Cell Immunol2, 199-207. L--.......

Gradoni, L., Davidson, RN., Orsini, S., Betto, P., Giambenedetti, M. (1993). Activity of liposomal amphotericin B (AmBisome) against Leishmania infantum and tissue distribution in mice. J Drug Target 1, 311-316. L~

Gradoni, L., Gramiccia, M. (1994). Leishmania infantum tropism: strain genotype or host immune status? Parasitol Today 10, 264-267. ~~

Gradoni, L., Guaraldi, G., Codeluppi, M., Scalone, A., Rivasi, F. (1995). Gastric localization of Leishmania in a patient with acquired immunodeficiency syndrome. A case report. Apmis 103, 25-28. ~

Gradoni, L., Pizzuti, R, Scalone, A., Russo, M., Gramiccia, M., di Martino, L., Pempinello, R, Gaeta, G.B. (1996). Recrudescence of visceral leishmaniasis unrelated to HIV infection in the Campania region ofItaly. Trans R Soc Trop Med Hyg 90,234-235: \r-

Green, S.J., Meltzer, M.S., Hibbs, J.B., Jr., Nacy, C.A. (1990). Activated macrophages destroy intracellular Leishmania major amastigotes, by an L-arginine-dependent killing mechanism. J Immunol144, 278-283.·~

Guerin, P.J., Olliaro, P., Sundar, S., Boelaert, M., Croft, S.L., Desjeux, P., Wasunna, M.K., Bryceson, A.D. (2002). Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2,494-501. ~

Guerrero Figueroa, R, Heath, RG., Escobar-Juyo, A., Caballero-Garcia, G., Blanco­Castillo, I. (2001). [Cortico-subcortical electrophysiological study during the effects ofbenzodiazepines in patients with panic disorders]. Rev Neurol32, 321-327.

Gupta, L., Talwar, A., Nishi, PaIne, S., Gupta, S., Chauhan, P.M. (2007). Synthesis of marine alkaloid: 8,9-dihydrocoscinamide B and its analogues as Novel class of antileishmanial agents. Bioorg Med Chem Lett 17, 4075-4079.

Gupta, S., Bhatia, RK (1975). India Practitioner 28,609. Gupta, S., Zehra, K, Nigam, V., Katiyar, J.C. (1992). Antileishmanial drug testing:

Appraisal on existing techniques. Ind J Parasitol16, 11. 1.

Gupta, S., Tiwari, S. (2000). Leishmania donovani infected Inbred Golden Hamster as Experimental Model for Visceral Leishmaniasis. J parasitic Diseases 24, 211-213.

Gupta, S., Tiwari, S., Bhaduri, A.P., Jain, G.K (2002). Anilino-(2-bromophenyl) acetonitrile: a promising orally effective antileishmanial agent. Acta Trop 84, 165-173. ~

Guru, P.Y., Agrawal, A.K, Singha, U.K, Singhal, A., Gupta, C.M. (1989). Drug targeting in Leishmania donovani infections using tufts in-bearing liposomes as drug vehicles. FEBS Lett 245,204-208.

Ha, D.S., Schwarz, J.K., Turco, SJ., Beverley, S.M. (1996). Use of the green fluorescent protein as a marker in transfected Leishmania. Mol Biochem Parasitol77, 57-64.

Haberman, M.C., Chapman, LJ., Numbers, J.S., McFall, RM. (1979). Relation of social competence to/scores on two scales of psychosis proneness. J Abnorm Psychol 88, 675-677. V

Habtemariam, S. (2003). In vitro antileishmanial effects of antibacterial diterpenes from two Ethiopian Premna species: P. schimperi and P. oligotricha. BMC Pharmacol3, 6.

Haidaris, C.G., Bonventre, P.P. (1982). A role for oxygen-dependent mechanisms in killing of Leishmania donovani tissue forms by activated macrophages. J Immunol 129, 850-855.\//

Haldar, J.P., Ghose, S., Saha, KC., Ghose, A.C. (1983). Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis. Infect Immun 42, 702-707. '.

187

References

Hanahan, D. (1983). Studies on transformation of Escherichia coli with plasmids. J Mol Bioi 166, 557-580.

Handman, E., Curtis, J.M. (1982). Leishmania tropica: surface antigens of intracellular and flagellate forms. Exp Parasitol54, 243-249.

Hannaert, V., Bringaud, F., Opperdoes, F.R, Michels, P.A. (2003). Evolution of energy metabolism and its compartmentation in Kinetoplastida. Kinetoplastid Bioi Dis 2, 11.

Hanson, C.L., Owsley, D.W. (1980). Frontal sinus size in Eskimo populations. Am J Phys Anthropol53, 251-255.

Hanson, W.L., Chapman, W.L., Jr., Kinnamon, KE. (1977). Testing of drugs for antileishmanial activity in golden hamsters infected with Leishmania donovani. Int J ParasitoI7,443-447.

Hardy, L.W., Matthews, W., Nare, B., Beverley, S.M. (1997). Biochemical and Genetic Tests for Inhibitors of Leishmania Pteridine Pathways. Exp Parasitol87, 158-170.

Hart, D.T., Coombs, G.H. (1982). Leishmania mexicana: energy metabolism ofamastigotes and promastigotes. Exp Parasitol54, 397-409.

Hart, D.T., Opperdoes, F.R (1984). The occurrence of glycosomes (microbodies) in the promastigote stage of four major Leishmania species. Mol Biochem Parasitol 13, 159-172.

Hart, D.T., Baudhuin, P., Opperdoes, F.R, de Duve, C. (1987). Biogenesis of the glycosome in Trypanosoma brucei: the synthesis, translocation and turnover of glycosomal polypeptides. Embo J 6, 1403-1411.

Hassan, M.M., Elraba'a, F.M., Ward, RD., Maingon, R.D., Elnaiem, D.A. (2004). Detection of high rates of in-village transmission of Leishmania donovani in eastern Sudan. Acta Trop 92, 77-82.

Havens, C.G., Bryant, N., Asher, L., Lamoreaux, L., Perfetto, S., Brendle, J.1., Werbovetz, K.A. (2000). Cellular effects of leishmanial tubulin inhibitors on L. donovani. Mol Biochem ParasitolllO, 223-236. ~

Hayashi, M., Vagi, M., Nito, K, Kamada, T., Nishimura, M. (2005). Differential Contribution of Two Peroxisomal Protein Receptors to the Maintenance of Peroxisomal Functions in Arabidopsis. J Bio Chem 280, 14829-14835. ~

Heath, KE., Campos-Barros, A., Toren, A., Rozenfeld-Granot, G., Carlsson, L.E., Savige, J., Denison, J.C., Gregory, M.C., White, J.G., Barker, D.F., Greinacher, A., Epstein, C.1., Glucksman, MJ., Martignetti, J.A. (2001). Nonmusc1e myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May­Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. Am J Hum Genet 69, 1033-1045.

Heiland, I., Erdmann, R (2005). Topogenesis of peroxisomal proteins does not require a functional cytoplasm-to-vacuole transport. Eur J Cell Bioi 84, 799-807. ~

Heim, R, Prasher, D.C., Tsien, RY. (1994). Wavelength mutations and posttranslational autoxidation of green fluorescent protein. Proc Natl Acad Sci USA 91, 12501-12504.

Heinzel, F.P., Sadick, M.D., Holaday, B.J., Coffman, RL., Locksley, RM. (1989). Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence'for expansion of distinct helper T cell subsets. J Exp Med 169, 59-72. ~

Heinzel, F.P., Sadick, M.D., Mutha, S.S., Locksley, RM. (1991). Production of interferon gamma, interleukin 2, inter!euldn 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and pr6gressive murine leishmaniasis. Proc Natl Acad Sci USA 88,7011-7015. ,:/

188

References

Heinzel, F.P., Schoenhaut, D.S., Rerko, R.M., Rosser, L.E., Gately, M.I<.. (1993). Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med 177, 1505-1509.

Helfert, S., Estevez, A.M., Bakker, B., Michels, P., Clayton, C. (2001). Roles of triosephosphate isomerase and aerobic metabolism in Trypanosoma brucei. Biochem J357,117-125. /-

Herwaldt, B.L. (1999). Leishmaniasis. Lancet 354, 1191-1199. v' Hibbs, J.B., Jr., Taintor, R.R., Vavrin, Z., Rachlin, E.M. (1988). Nitric oxide: a cytotoxic

activated macrophage effector molecule. Biochem Biophys Res Commun 157, 87-94. Ho, J.L., Reed, S.G., Wick, E.A., Giordano, M. (1990). Granulocyte-macrophage and

macrophage colony-stimulating factors activate intramacrophage killing of Leishmania mexicana amazonensis. J Infect Dis 162, 224-230.

Ho, M., Koech, D.K., Iha, D.W., Bryceson, A.D. (1983). Immunosuppression in Kenyan visceral leishmaniasis. Clin Exp Immunol51, 207-214.

Hohmann, S., Neves, M.J., de Koning, W., Alijo, R., Ramos, J., Thevelein, J.M. (1993). The growth and signalling defects of the ggsl (fdpl/bypl) deletion mutant on glucose are suppressed by a deletion of the gene encoding hexokinase PII. Curr Genet 23,281-289.

Hohmann, S., Bell, W., Neves, MoI., Valckx, D., Thevelein, J.M. (1996). Evidence for trehalose-6-phosphate-dependent and -independent mechanisms in the control of sugar influx into yeast glycolysis. Mol Microbiol20, 981-991.

Hommel, M., Jaffe, C.L., Travi, B., Milon, G. (1995). Experimental models for leishmaniasis and for testing anti-Ieishmanial vaccines. Ann Trop Med Parasitol 89 Suppll,55-73.

Hommel, M. (1999). Visceral leishmaniasis: biology of the parasite. J Infect 39, 101-111. Honore, S., Garin, Y.J., Sulahian, A., Gangneux, J.P., Derouin, F. (1998). Influence of the:

host and parasite strain in a mouse model of visceral Leishmania infantum infection. FEMS Immunol Med Microbiol21, 231-239.

Hoover, D.L., Nacy, C.A., Meltzer, M.S. (1985). Human monocyte activation for cytotoxicity against intracellular Leishmania donovani amastigotes: induction of microbicidal activity by interferon-gamma. Cell Immunol94, 500-511.

Hotez, PoI., Remme, J.H., Buss, P., Alleyne, G., Morel, C., Breman, J.G. (2004). Combating tropical infectious diseases: report of the Disease Control Priorities in Developing Countries Project. Clin Infect Dis 38,871-878.

Huang, T.T., Carlson, E.J., Gillespie, A.M., Shi, Y., Epstein, C.J. (2000). Ubiquitous overexpression of CuZn superoxide dismutase does not extend life span in mice. J Gerontol A Bioi Sci Med Sci 55, B5-9.

Hudock, M.P., Sanz-Rodriguez, C.E., Song, Y., Chan, J.M., Zhang, Y., Odeh, S., Kosztowski, T., Leon-Rossell, A., Concepcion, J.L., Yardley, V., Croft, S.L., Urbina, J.A., Oldfield, E. (2006). Inhibition of Trypanosoma cruzi hexokinase by bisphosphonates. J Med Chem 49, 215-223.

Ilgoutz, S.c., McConville, M.J. (2001). Function and assembly of the Leishmania surface coat. Int J Paras ito I 31, 899-908.

Imlay, J.A., Linn, S. (1988). DNA damage and oxygen radical toxicity. Science 240, 1302-1309.

Irunberry, J., Pilo Moron, E., Neel, R. (1968). [The evolution of serum proteins during human rabies from street virus]. Ann Inst Pasteur (Paris) 114,331-338.

Ivens, A.C., Peacock, C.S., Worthey, E.A., Murphy, L., Aggarwal, G., Berriman, M., Sisk, E., Rajandream, M.A., Adlem, E., Aert, R., Anupama, A., Apostolou, Z., Attipoe, P., Bason, N., Bauser, C., Beck, A., Beverley, S.M., Bianchettin, G., Borzym, K.,

189

References

Bothe, G., Bruschi, C.V., Collins, M., Cadag, E., Ciarloni, L., Clayton, C., Coulson, RM., Cronin, A., Cruz, A.K., Davies, RM., De Gaudenzi, J., Dobson, D.E., Duesterhoeft, A., Fazelina, G., Fosker, N., Frasch, A.C., Fraser, A., Fuchs, M., Gabel, C., Goble, A., Goffeau, A., Harris, D., Hertz-Fowler, C., Hilbert, H., Hom, D., Huang, Y., Klages, S., Knights, A., Kube, M., Larke, N., Litvin, L., Lord, A., Louie, T., Marra, M., Masuy, D., Matthews, K., Michaeli, S., Mottram, J.C., Muller­Auer, S., Munden, H., Nelson, S., Norbertczak, H., Oliver, K., O'Neil, S., Pentony, M., Pohl, T.M., Price, C., Pumelle, B., Quail, M.A., Rabbinowitsch, E., Reinhardt, R., Rieger, M., Rinta, J., Robben, J., Robertson, L., Ruiz, J.C., Rutter, S., Saunders, D., Schafer, M., Schein, J., Schwartz, D.C., Seeger, K., Seyler, A., Sharp, S., Shin, H., Sivam, D., Squares, R., Squares, S., Tosato, V., Vogt, C., Volckaert, G., Wambutt, R, Warren, T., Wedler, H., Woodward, J., Zhou, S., Zimmermann, W., Smith, D.F., Blackwell, J.M., Stuart, K.D., Barrell, B., Myler, P.J. (2005). The genome of the kinetoplastid parasite, Leishmania major. Science 309, 436-442.

Iyengar, R, Stuehr, D.J., MarIetta, M.A. (1987). Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst. Proc Natl Acad Sci USA 84, 6369-6373. V

Jackson, J.E., Tally, J.D., Tang, D.B. (1989). An in vitro micromethod for drug sensitivity testing of Leishmania. Am J Trop Med Hyg 41,318-330.

Jacob, V.P., Kalra, S.L. (1951). Kala-azar in Kashmir. Indian J Med Res 39, 323-327. ~ Jacobs, W.R, Barletta, RG., Udani, J., R , Chan, J., Kalkut, G., Kieser, T., Sarkis, G.T., /"

Hatfull, G.F., Bloom, B.R. (1993). Rapid assessment of drug susceptibility of Mycobacterium tuberculosis by means of luciferase reporter phages. Science 260, 819-822.

Jacobson, M.D. (1996). Reactive oxygen species and programmed cell death. Trends Biochem Sci 21, 83-86.

Jacquet, D., Boelaert, M., Seaman, J., Rijal, S., Sundar, S., Menten, J., Magnus, E. (2006). Comparative evaluation of freeze-dried and liquid antigens in the direct agglutination test for serodiagnosis of visceral leishmaniasis (ITMA-DATNL). Trop Med Int Health 11, 1777-1784.

Jardim, A., Liu, W., Zheleznova, E., Ullman, B. (2000). Peroxisomal targeting signal-1 receptor protein PEX5 from Leishmania donovani. Molecular, biochemical, and immunocytochemical characterization. J Bioi Chern 275, 13637-13644.

Jardim, A., Rager, N., Liu, W., Ullman, B. (2002). Peroxisomal targeting protein 14 (PEXI4) from Leishmania donovani. Molecular, biochemical, and immunocytochemical characterization. Mol Biochem Parasitol124, 51-62.

Jha, S.N., Singh, N.K., Jha, T.K. (1991). Changing response to diamidine compounds in cases ofkala-azar unresponsive to antimonial. J Assoc Physicians India 39,314-316.

Jha, T.K. (1983). Evaluation of diamidine compound (pentamidine isethionate) in the treatment resistant cases of ka1a-azar occurring in North Bihar, India. Trans R Soc Trop MedHyg 77, 167-170. '\.-

Jha, T.K., Olliaro, P., Thakur, C.P., Kanyok, T.P., Singhania, B.L., Singh, I.J., Singh, N.K., Akhoury, S., Jha, S. (1998). Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India. Em} 316, 1200-1205.

Jha, T.K., Sundar, S., Thakur, c.P., Bachmann, P., Karbwang, J., Fischer, c., Voss, A., Berman, J. (1999). Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N Engl J Med 341, 1795-1800.

190

References

Jha, T.K., Sundar, S., Thakur, C.P., Felton, J.M., Sabin, A.J., Horton, J. (2005). A phase II dose-ranging study of sitamaquine for the treatment of visceral leishmaniasis in India. Am J Trop Med Hyg 73, 1005-1011.

Joshi, P.B., Kelly, B.L., Kamhawi, S., Sacks, D.L., McMaster, W.R (2002). Targeted gene deletion in Leishmania major identifies leishmanolysin (GP63) as a virulence factor. Mol Biochem Parasitol120, 33-40.

Kamau, S.W., Grimm, F., Hehl, A.B. (2001). Expression of green fluorescent protein as a marker for effects of antileishmanial compounds in vitro. Antimicrob Agents Chemother 45,3654-3656.

Kamhawi, S., Modi, G.B., Pimenta, P.F., Rowton, E., Sacks, D.L. (2000). The vectorial competence of Phlebotomus sergenti is specific for Leishmania tropica and is controlled by species-specific, lipophosphoglycan-mediated midgut attachment. Parasitology 121 ( Pt 1), 25-33. V--

Kamil, A.A., Khalil, E.A., Musa, A.M., Modabber, F., Mukhtar, M.M., Ibrahim, M.E., Zijlstra, E.E., Sacks, D., Smith, P.G., Zicker, F., EI-Hassan, A.M. (2003). Alum­precipitated autoclaved Leishmania major plus bacille Calmette-Guerrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers. Trans R Soc Trop Med Hyg 97, 365-368.

Kaneshiro, E.S., Jayasimhulu, K., Lester, RL. (1986). Characterization of inositol lipids from Leishmania donovani promastigotes: identification of an inositol sphingophospholipid. J Lipid Res 27, 1294-1303.

Kapoor, P., Sahasrabuddhe, A.A., Kumar, A., Mitra, K., Siddiqi, M.I., Gupta, C.M. (2008). AN UNCONVENTIONAL FORM OF ACTIN IN PROTOZOAN HAEMOFLAGELLATE, LEISHMANIA. JBC in Press.

Karp, c.L., el-Safi, S.H., Wynn, T.A., Satti, M.M., Kordofani, A.M., Hashim, F.A., Hag­Ali, M., Neva, F.A., Nutman, T.B., Sacks, D.L. (1993). In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-l0 and interferon­gamma. J Clin Invest 91, 1644-1648.

Karplus, T.M., Jeronimo, S.M., Chang, H., Helms, B.K., Burns, T.L., Murray, J.C., Mitchell, A.A., Pugh, E.W., Braz, R.F., Bezerra, F.L., Wilson, M.E. (2002). Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection. Infect Immun 70, 6919-6925.

Katoh, M. (1981). Studies of lysosomal enzymes in macrophages. III. Lysosomal enzyme activities in cultured macrophages infected with some species of mycobacteria. Hiroshima J Med Sci 30, 99-107. V

Kaul, S.M., Sharma, R.S., Borgohain j Bj\ .. , Das, N.S., verghese, T. (1994). Absence of Phlebotomus argentipes Ann & Brun. (Diptera: Psychodidae) the vector of Indian kala-azar from Kamrup district, Assam. J Commun Dis 26, 68-74.

Keenan, C.M., Hendricks, L.D., Lightner, L., Webster, H.K., Johnson, A.J. (1984). Visceral leishmaniasis in the German shepherd dog. I. Infection, clinical disease, and clinical pathology. Vet Pathol21, 74-79.

Kellinghaus, C., Loddenkemper, T., Najm, I.M., Wyllie, E., Lineweaver, T., Nair, D.R, Luders, H.O. (2004). Specific epileptic syndromes are rare even in tertiary epilepsy centers: a patient-oriented approach to epilepsy classification. Epilepsia 45, 268-275.

Kemp, K., Kemp, M., Kharazmi, A., Ismail, A., Kurtzhals, J.A., Hviid, L., Theander, T.G. (1999). Leishmania-specific T cells expressing interferon-gamma (lFN-gamma) and IL-I0 upon activation are expanded in individuals cured of visceral leishmaniasis. Clin Exp Immunol116, 500-504.

191

References

Kemp, M., Kurtzhals, J.A., Kharazmi, A., Theander, T.G. (1994). Dichotomy in the human CD4+ T-cell response to Leishmania parasites. Apmis 102, 81-88.

Kempe, A., Wise, P.H., Wampler, N.S., Cole, F.S., Wallace, H., Dickinson, C., Rinehart, H., Lezotte, D.C., Beaty, B. (1997). Risk status at discharge and cause of death for postneonatal infant deaths: a total population study. Pediatrics 99, 338-344.

Kenney, RT., Sacks, D.L., Gam, A.A., Murray, H.W., Sundar, S. (1998). Splenic cytokine responses in Indian kala-azar before and after treatment. J Infect Dis 177, 815-818.

Kettle, D.S. (1995). Medical and Veterinary Entomology. Cab International, Cambridge, 725.

Khan, A.R., Tripathi, RP., Bhaduri, A.P., Sahai, R, Puri, A., Tripathi, L.M., Srivastava, V.M.L. (2001). Eur J Med Chem 36, 103-106.

Khoo, S.H., Bond, J., Denning, D.W. (1994). Administering amphotericin B--a practical approach. J Antimicrob Chemother 33,203-213.

Kiderlen, A.F., Kaye, P.M. (1990). A modified colorimetric assay of macrophage activation for intracellular cytotoxicity against Leishmania parasites. J Immunol Methods 127, 11-18.

Kikuth, C.W., Schmidt, H. (1937). Contribution to the progress of antimony treatment of Kala-azar. Clin Med J 52, 425. \~

Killick-Kendrick, R (1999). The biology and control of phlebotomine sand flies. Clin Dermato/17,279-289.

Kima, P.E., Constant, S.L., Hannum, L., Colmenares, M., Lee, K.S., Haberman, A.M., Shlomchik, M.J., McMahon-Pratt, D. (2000). Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. J Exp Med 191, 1063-1068.

Kinnamon, K.E., Steck, E.A., Loizeaux, P.S., Hanson, W.L., Chapman, W.L., Jr., Waits, V.B. (1978). The antileishmanial activity of lepidines. Am J Trop Med Hyg 27, 751-757.

Klein, A.T., van den Berg, M., Bottger, G., Tabak, H.F., Distel, B. (2002). Saccharomyces cerevisiae acyl-CoA oxidase follows a novel, non-PTSl, import pathway into peroxisomes that is dependent on Pex5p. J Bioi Chem 277, 25011-25019.

Klein, R, Schwenk, M., Ramm, R.H., Templeton, D. (2004). DIAGNOSTIC RELEV ANCE OF THE LYMPHOCYTE TRANSFORMA TION TEST FOR SENSITIZA nON TO BERYLLIUM AND OTHER METALS. Pure Appl. Chem. 76, 1269-1281.

Knighton, D.R, Kan, c.c., Howland, E., Janson, C.A., Hostomska, Z., Welsh, K.M., Matthews, D.A. (1994). Structure of and kinetic channelling in bifunctional dihydrofolate reductase-thymidy late synthase. Nat Struct Bioi 1, 186-194.

Kolter, T., Proia, RL., Sandhoff, K. (2002). Combinatorial ganglioside biosynthesis. J Bioi Chem 277, 25859-25862.

Komori, M., Rasmussen, S.W., Kie1, lA., Baerends, RJ., Cregg, J.M., van der Klei, 1.1., Veenhuis, M. (1997). The Hansenula polymorph a PEX14 gene encodes a novel peroxisomal membrane protein essential for peroxisome biogenesis. Embo J 16,44-53.

Koutinas, A.F., Saridomichelakis, M.N., Mylonakis, M.E., Leontides, L., Polizopoulou, Z., Billinis, C., Argyriadis, D., Diakou, N., Papadopoulos, o. (2001). A randomised, blinded, placebo-controlled clinical trial with allopurinol in canine leishmaniosis. VIlI Paro.ffrM! g~, 247-%1.

K.i'iiUtl-\-~!§~~!1 !U:;;~ Q:?:?H1hf ~Jf, (1 ~~~)! mm:;)'mt3~ of iJHm~i1B 1I1iol llleUlIJolI§m !:l!j OFU~ targets.ParmilOl Todoyl§, 404-409,

192

References

Krishnamurthy, G., Vikram, R, Singh, S.B., Patel, N., Agarwal, S., Mukhopadhyay, G., Basu, S.K, Mukhopadhyay, A. (2005). Hemoglobin receptor in Leishmania is a hexokinase located in the flagellar pocket. J Bioi Chem 280, 5884-5891.

Kroeger, A., Avila, E.V., Morison, L. (2002). Insecticide impregnated curtains to control domestic transmission of cutaneous leishmaniasis in Venezuela: cluster randomised trial. Bmj 325, 810-813.

Kumar, R, Pai, K, Sundar, S. (2001). Reactive oxygen intermediates, nitrite and IFN­gamma in Indian visceral leishmaniasis. Clin Exp Immunol124, 262-265. l--­

Kunau, W.H. (2001). Peroxisom~<;:s: the extended shuttle to the peroxisome matrix. Curr BiolH, R659-662. ~

Lane, R.P. (1993). Sandflies (Phlebotominae). In RP Lane & RW Cross key (eds), Medical Insects and Arachnids, Chapman & Hall, London 78-119.

Lang, T., Goyard, S., Lebastard, M., Milon, G. (2005). Bioluminescent Leishmania expressing luciferase for rapid and high throughput screening of drugs acting on amastigote-harbouring macrophages and for quantitative real-time monitoring of parasitism features in living mice. Cell Microbiol7, 383-392.

Larson, E.M., Doughman, DJ., Gregerson, D.S., Obritsch, W.F. (1997). A new, simple, nonradioactive, nontoxic in vitro assay to monitor corneal endothelial cell viability. Invest Ophthalmol Vis Sci 38, 1929-1933.

Lazarow , P.B., Fujiki, Y. (1985). Biogenesis of peroxisomes. Annu Rev Cell Bioi 1, 489-530.

Le Blancq, S.M., Belehu, A., Peters, W. (1986). Leishmania in the Old World: 3. The distribution ofL. aethiopica zymodemes. Trans R Soc Trop Med Hyg 80,360-366.

Le Blancq, S.M., Peters, W. (1986). Leishmania in the Old World: 2. Heterogeneity among L. tropica zymodemes. Trans R Soc Trop Med Hyg 80, 113-119.

Ie Fichoux, Y., Quaranta, J.F., Aufeuvre, J.P., Lelievre, A., Marty, P., Suffia, I., Rousseau, D., Kubar, J. (1999). Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in southern France. J Clin Microbiol37, 1953-1957.

Lee, N., Bertholet, S., Debrabant, A., Muller, J., Duncan, R, Nakhasi, H.L. (2002). Programmed cell death in the unicellular protozoan parasite Leishmania. Cell Death Differ 9, 53-64.

Legare, D., Papadopoulou, B., Roy, G., Mukhopadhyay, R, Haimeur, A., Dey, S., Grondin, K, Brochu, C., Rosen, B.P., Ouellette, M. (1997). Exp Parasitol87, 275-282.

Liew, F.Y., Li, Y., Millott, S. (1990a). Tumour necrosis factor (TNF-alpha) In

leishmaniasis. II. TNF-alpha-induced macrophage leishmanicidal activity is mediated by nitric oxide from L-arginine. Immunology 71, 556-559. ~-

Liew, F.Y., Li, Y., Millott, S. (1990b). Tumor necrosis factor-alpha synergizes with IFN­gamma in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol145, 4306-4310. \.'

Liew, F.Y., Millott, S., Parkinson, c., Palmer, RM., Moncada, S. (1990c). Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J Immunol144, 4794-4797. \..

Liew, F.Y., Parkinson, C., Millott, S., Severn, A., Carrier, M. (1 990d). Tumour necrosis factor (TNF alpha) in leishmaniasis. I. TNF alpha mediates host protection against cutaneous leishmaniasis. Immunology 69,570-573. \./

Liew, F.Y. (1991). The effector mechanism and vaccination against cutaneous leishmaniasis. Behring Inst Mitt, 239-243. V

Lin, R, Tarr, P.E., Jones, T.C. (1995). Present status of the use of cytokines as adjuvants with vaccines to protect against infectious diseases. Clin Infect Dis 21, 1439-1449.

193

References

Lin, R, Jones, T.C. (1997). Vaccine Adjuvants: A New Hope for Effective Immunizations. Braz J Infect Dis 1, 106-122.

Lira, R, Sundar, S., Makharia, A., Kenney, R, Gam, A., Saraiva, E., Sacks, D. (1999). Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. J Infect Dis 180, 564-567.

Louzir, H., Melby, P.C., Ben Salah, A., Marrakchi, H., Aoun, K, Ben Ismail, R, Dellagi, K (1998). Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major. J Infect Dis 177, 1687-1695.

Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, RJ. (1951). Protein measurement with the Folin phenol reagent. J Bioi Chem 193,265-275.

Lucumi, A., Robledo, S., Gama, V., Saravia, N.G. (1998). Antimicrob Agents Chemother 42, 1990-1995.

Luyten, K., de Koning, W., Tesseur, I., Ruiz, M.C., Ramos, J., Cobbaert, P., Thevelein, J.M., Hohmann, S. (1993). Disruption of the Kluyveromyces lactis GGS1 gene causes inability to grow on glucose and fructose and is suppressed by mutations that reduce sugar uptake. Eur J Biochem 217, 701-713.

Maarouf, M., Adeline, M.T., Solignac, M., Vautrin, D., Robert-Gero, M. (1998). Development and characterization of paromomycin-resistant Leishmania donovani promastigotes. Parasite 5, 167-173.

Mackeness, G.B. (1970). In: Mudd S (ed) Infectious agents and host reactions. Philadelphia PA, WB Saunders, 62-67.

MacMicking, J., Xie, Q.W., Nathan, C. (199]). Nitric oxide and macrophage function. Annu Rev Immunol15, 323-350. L/

Madindou, T.J., Hanson, W.L., Chapman, W.L., Jr. (1985). Chemotherapy of visceral leishmaniasis (Leishmania donovani) in the squirrel monkey (Saimiri sciureus). Ann Trop Med Parasitol79, 13-19.,

Madrid, K.P., De Crescenzo, G., Wang, S., Jardim, A. (2004). Modulation of the Leishmania donovani peroxin 5 quaternary structure by peroxisomal targeting signal 1 ligands. Mol Cell Bioi 24, 7331-7344:-~

Madrid, K.P., Jardim, A. (2005). Peroxin 5-peroxin 14 association in the protozoan Leishmania donovani involves a novel protein-protein interaction motif. Biochem J 391, 105-114. ~

Manson-Bahr, P.E. (1996). A primary skin lesion in visceral leishmaniasis. Clin Infect Dis 22,376-377.

Marr, J. (1980). Carbohydrate metabolism in Leishmania. In: Levandowsky M, Hunter SH (eds) Biochemistry and physiology of Protozoa, 2nd edn. Academic Press, New York, pp 313-340.

Marsden, P.D., Lumsden, W.H. (1971). Trypanosomiasis and leishmaniasis. Practitioner 207, 181-185.

Marshall, B.G., Kropf, P., Murray, K, Clark, C., Flanagan, A.M., Davidson, R.N., Shaw, RJ., Muller, I. (2000). Bronchopulmonary and mediastinal leishmaniasis: an unusual clinical presentation of Leishmania donovani infection. Clin Infect Dis 30, 764-769.

Martin, E., Simon, M.W., Schaefer, F.W., 3rd, Mukkada, A.J. (1976). Enzymes of carbohydrate metabolism in four human species of Leishmania: a comparative survey. J Protozool23, 600-607.

Mattock, N.M., Peters, W. (1975). The experimental chemotherapy of leishmaniasis. I: Techniques for the study of drug action in tissue culture. Ann Trop Med Paras ito I 69,349-357.

194

References

Mauel, J., Ransijn, A., Buchmuller-Rouiller, Y. (1991). Killing of Leishmania parasites in activated murine macrophages is based on an L-arginine-dependent process that produces nitrogen derivatives. J Leukoc Bioi 49, 73-82.

Mauricio, LL., Stothard, J.R, Miles, M.A. (2000). The strange case of Leishmania chagasi. . /' Parasltol Today 16, 188-189.0/ McFadden, D.C., Seeber, F., Boothroyd, J.C. (1997). Use of Toxoplasma gondii expressing

beta-galactosidase for colorimetric assessment of drug activity in vitro. Antimicrob Agents Chemother 41, 1849-1853.

McHugh, C.P., Thies, M.L., Melby, P.C., Yantis, L.D., Jr., Raymond, RW., Villegas, M.D., Kerr, S.F. (2003). Short report: a disseminated infection of Leishmania mexicana in an eastern woodrat; Neotoma floridana, collected in Texas. Am J Trop Med Hyg 69, 470-472. V

McKinney, L.A., Hendricks, L.D. (1980). Experimental infection of Mystromys albicaudatus with Leishmania braziliensis: pathology. Am J Trop Med Hyg 29, 753-760.

McLeod, R, Muench, S.P., Rafferty, lB., Kyle, D.E., Mui, E.J., Kirisits, MJ., Mack, D.G., Roberts, C.W., Samuel, B.U., Lyons, RE., Dorris, M., Milhous, W.K, Rice, D.W. (2001). Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition ofapicomplexan Fab LInt J Parasito/31, 109-113. L----

McSorley, S., Proudfoot, L., O'Donnell, C.A., Liew, F.Y. (1996). Immunology of murine leishmaniasis. Clin Dermato/14, 451-464.

Medina-Acosta, E., Cross, G.A. (1993). Rapid isolation of DNA from trypanosomatid protozoa using a simple 'mini-prep' procedure. Mol Biochem Parasitol59, 327-329.

Melby, P.C., Yang, J., Zhao, W., Perez, L.E., Cheng, J. (2001). Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis. Infect Immun 69, 4719-4725.

Merrill, A.H., Jr., Wang, E., Gilchrist, D.G., Riley, RT. (1993). Fumonisins and other inhibitors of de novo sphingolipid biosynthesis. Adv Lipid Res 26, 215-234.

Michels, P.A., Hannaert, V. (1994). The evolution of kine top las tid glycosomes. J Bioenerg Biomembr 26,213-219.

Michels, P.A., Bringaud, F., Herman, M., Hannaert, V. (2006). Metabolic functions of glycosomes in trypanosomatids. Biochim Biophys Acta 1763, 1463-1477.

Mikhail, J.W., Mansour, N.S. (1973). Mystromys albicaudatus, the African white-tailed rat, as an experimental host for Leishmania donovani. J Parasitol59, 1085-1087.

Mikhail, J.W., Mansour, N.S. (1975). Leishmania donovani: therapeutic and prophylaciic action of antimony dextran glycoside (RL-712) in the golden hamster. Exp Parasitol 37,348-352.

Mikus, J., Steverding, D. (2000). A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue. ParasitolInt 48,265-269.

Miles, M.A., Lainson, R, Shaw, J.J., Povoa, M., de Souza, A.A. (1981). Leishmaniasis in Brazil: XV. Biochemical distinction of Leishmania mexicana amazonensis, L. braziliensis braziliensis and L. braziliensis guyanensis--aetiological agents of cutaneous leishmaniasis in the Amazon Basin of Brazil. Trans R Soc Trop Med Hyg 75,524-529.

Mishra, RC., Tewari, N., Arora, K, Ahmad, R, Tripathi, R.P., Tiwari, V.K, Walter, RD., Srivastava, A.K (2003). Comb Chem Highthroughput Screen 6,37-51. V---

Misset, 0., Bos, O.l, Opperdoes, F.R (1986). Glycolytic enzymes of Trypanosoma brucei. Simultaneous purification, intraglycosomal concentrations and physical properties. Eur J Biochem 157, 441-453. \...-- ,/

195

References

Misslitz, A., Mottram, J.C., Overath, P., Aebischer, T. (2000). Targeted integration into a rRNA locus results in uniform and high level expression of transgenes in Leishmania amastigotes. Mol Biochem Parasito/l07, 251-261.

Moncada, S., Palmer, R.M., Higgs, E.A. (1989a). The biological significance of nitric oxide formation from L-arginine. Biochem Soc Trans 17, 642-644. 1//'

Moncada, S., Palmer, R.M., Higgs, E.A. (1989b). Biosynthesis of nitric oxide from L­arginine. A pathway for the regulation of cell function and communication. Biochem Pharmacol38, 1709-1715. \.../'"

Monte-Alegre, A., Ouaissi, A., Sereno, D. (2006). Leishmania amastigotes as targets for drug screening. Kinetoplastid Bioi Dis 5, 6.

Mookerjee Basu, J., Mookerjee, A., Sen, P., Bhaumik, S., Sen, P., Banerjee, S., Naskar, K, Choudhuri, S.K, Saha, B., Raha, S., Roy, S. (2006). Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmania donovani-infected macrophages. Antimicrob Agents Chemother 50, 1788-1797.

More, B., Bhatt, H., Kukreja, V., Ainapure, S.S. (2003). Miltefosine: great expectations . against visceral leishmaniasis. J Postgrad Med 49, 101-103.

Morita, Y.S., Paul, KS., Englund, P.T. (2000). Specialized fatty acid synthesis in African trypanosomes: myristate for GPI anchors. Science 288, 140-143. \...--'"

Morris, J.C., Wang, Z., Drew, M.E., Englund, P.T. (2002). Glycolysis modulates trypanosome glycoprotein expression as revealed by an RNAi library. EMBO 21, 4429-4438.

Morris, M.T., De Bruin, C., Yang, Z., Chambers, J.W., Smith, KS., Morris, J.C. (2006). Activity of a Second Trypanosoma brucei Hexokinase Is Controlled by an 18-Amino-Acid C Terminal Tail. Euk Cell 5, 2014-2023.

Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: apRlication to proliferation and cytotoxicity assays. J Immunol Methods 65, 55-63. ~

Mottram, J.C., Coombs, G.H. (1985). Leishmania mexicana: subcellular distribution of enzymes in amastigotes and promastigotes. Exp Parasito/59, 265-274.

Mottram, J.C., Souza, A.E., Hutchison, J.E., Carter, R., Frame, M.J., Coombs, G.H. (1996). Evidence from disruption of the lmcpb gene array of Leishmania mexicana that cysteine proteinases are virulence factors. Proc Natl Acad Sci USA 93, 6008-6013.

Moyersoen, J., Choe, J., Kumar, A, Voncken, F.G., HoI, W.G., Michels, P.A. (2003). Characterization of Trypanosoma brucei PEX14 and its role in the import of glycosomal matrix proteins. Eur J Biochem 270, 2059-2067.

Mukhopadhyay, R., Dey, S., Xu, N., Gage, D., Lightbody, J., Ouellette, M., Rosen, B.P. (1996). Proc Natl Acad Sci USA. 93, 10383-10387.

Mukhopadhyay, S., Srivastava, V.M., Murthy, P.K, Hasnain, S.E. (2004). Poorer NF-kappa B signaling by microfilariae in macrophages from BALB/c mice affects their ability to produce cytotoxic levels of nitric oxide to kill microfilariae. FEBS Lett 567, 275-280.

Muller, I., Milon, G., Louis, J. (1991). T-celtresponses during infections with Leishmania major. Behring Inst Mitt, 80-83. V

Munoz-Fernandez, M.A, Fernandez, M.A, Fresno, M. (1992). Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF -alpha and IFN-gamma through a nitric oxide-dependent mechanism. Immunol Lett 33,35-40.

Murray, H.W. (1981). Interaction of Leishmania with a macrophage cell line. Correlation between intracellular killing and the generation of oxygen intermediates. J Exp Med 153, 1690-1695. ~

196

References

Murray, H.W. (1982). Cell-mediated immune response in experimental visceral leishmaniasis. II. Oxygen-dependent killing of intracellular Leishmania donovani amastigotes. J Immunol129, 351-357.

Murray, H.W., Masur, H., Keithly, J.S. (1982). Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity. J Immunol129, 344-350.

Murray, H.W., Rubin, B.Y., Carriero, S.M., Harris, A.M., Jaffee, E.A. (1985). Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen­independent activity against intracellular Toxoplasma gondii. J Immunol134, 1982-1988.

Murray, H.W., Stern, J.J., Welte, K., Rubin, B.Y., Carriero, S.M., Nathan, C.F. (1987). Experimental visceral leishmaniasis: production of interleukin 2 and interferon­gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma. J Immunol138, 2290-2297.

Murray, H.W. (1988). Survival of intracellular pathogens within human mononuclear phagocytes. Semin Hematol25, 101-111.

Murray, H.W., Oca, M.J., Granger, A.M., Schreiber, R.D. (1989). Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis. J Clin Invest 83, 1253-1257.

Murray, H.W., Teitelbaum, R.F. (1992). L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J Infect Dis 165, 513-517.

Murray, H.W., Hariprashad, J., Ficht!, R.E. (1993). Treatment of experimental visceral leishmaniasis in a T-cell-deficient host: response to amphotericin Band pentamidine. Antimicrob Agents Chemother 37, 1504-1505.

Murray, H.W. (1997). Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis. J Infect Dis 175, 1477-1479.

Murray, H.W., Pepin, J., Nutman, T.B., Hoffman, S.L., Mahmoud, A.A. (2000). Tropical medicine. Bm} 320, 490-494.

Murray, H.W. (2001). Clinical and experimental advances in treatment of visceral leishmaniasis. Antimicrob Agents Chemother 45,2185-2197.

Nacy, C.A., Fortier, A.H., Meltzer, M.S., Buchmeier, N.A., Schreiber, R.D. (1985). Macrophage activation to kill Leishmania major: activation of macrophages for intracellular destruction of amastigotes can be induced by both recombinant interferon-gamma and non-interferon lymphokines. J Immunol135, 3505-3511.

Nacy, C.A., Nelson, BJ., Meltzer, M.S., Green, S.J. (1991). Cytokines that regulate macrophage production of nitrogen oxides and expression of antileishmanial activities. Res Immunol142, 573-576.

Nair, D.M., Purdue, P.E., Lazarow, P.B. (2004a). Pex7p translocates in and out of peroxisomes in Saccharomyces cerevisiae. J Cell Bioi 167, 599-604.

Nair, P., Barrett, A.W., Theodossy, T. (2004b). Oral nodular fasciitis: case report. Br J Oral Maxillofac Surg 42,360-362.

Nakashima, H., Pauwels, R., Baba, M., Schols, D., Desmyter, J., De Clercq, E. (1989). Tetrazolium-based plaque assay for HIV-l and HIV-2, and its use in the evaluation of antiviral compounds. J Virol Methods 26,319-329.

Nakayama, G.R., Caton, M.C., Nova, M.P., Parandoosh, Z. (1997). Assessment of the Alamar Blue assay for cellular growth and viability in vitro. J Immunol Methods 204, 205-208. .

197

References

Nakayama, H., Desrivot, J., Bories, C., Franck, X., Figadere, B., Hocquemiller, R, Fournet, A., Loiseau, P.M. (2007). In vitro and in vivo antileishmanial efficacy of a new nitrilquinoline against Leishmania donovani. Biomed Pharmacother 61, 186-188.

Napier, L.E., Smith, RO.A. (1926). A study of the bionomics of Phlebotomus argentipes with special reference of conditions in Calcutta. Ind Med Res Memor 4, 161. ~

Nare, B., Hardy, L.W., Beverley, S.M. (1997a). The roles of pteridine reductase 1 and dihydrofolate reductase-thymidylate synthase in pteridine metabolism in th(~

protozoan parasite Leishmania major. J Bioi Chem 272, 13883-13891. Nare, B., Luba, J., Hardy, L.W., Beverley, S. (1997b). New approaches to Leishmania

chemotherapy: pteridine reductase 1 (PTRI) as a target and modulator of antifolate sensitivity. Parasitology 114 Suppl, SI01-110.

Naula, C., Seebeck, T. (2000}._Cyclic AMP signaling in trypanosomatids. Parasitol Today 16,35-38. ~

Naula, C., Parsons, M., Mottram, J.C. (2005). Protein kinases as drug targets in trypanosomes and Leishmania. Biochim Biophys Acta 1754, 151-159. '\.....-...--­

Neal, RA., Matthews, PJ. (1982). In vivo antileishmanial properties of pentavalent antimonial compounds. Trans R Soc Trop Med Hyg 76, 284.

Neal, RA. (1984). Leishmania major: culture media, mouse strains, and promastigote virulence and infectivity. Exp Parasitol57, 269-273.

Neal, RA., Croft, S.L. (1984). An in-vitro system for determining the activity of compounds against the intracellular amastigote form of Leishmania donovani. J Antimicrob Chemother 14, 463-475.

Neogy, A.B., Nandy, A., Ghosh Dastidar, B., Chowdhury, A.B. (1988). Modulation of the cell-mediated immune response in kala-azar and post-kala-azar dermal leishmaniasis in relation to chemotherapy. Ann Trop Med Parasitol82, 27-34.

Nickol, A.D., Bonventre, P.F. (1985). Immunosuppression associated with visceral leishmaniasis of hamsters. Parasite Immunol7, 439-449. 1''--___ _

Niederhoff, K., Meindl-Beinker, N.M., Kerssen, D., Perband, U., Schafer, A., Schliebs, W., Kunau, W.H. (2005). Yeast Pex14p possesses two functionally distinct Pex5p and one Pex7p binding sites. J Bioi Chem 280,35571-35578. 'L----

Nito, K., Hayashi, M., Nishimura, M. (2002). Direct interaction and determination of binding domains among peroxisomal import factors in Arabidopsis thaliana. Plant Cell Physiol43, 355-366. ~

Nolan, TJ., Farrell, J.P. (1987). Experimental infections of the multimammate rat (Mastomys natalensis) with Leishmania donovani and Leishmania major. Am J Trop Med Hyg 36, 264-269.

Nuzum, E., White, F., 3rd, Thakur, C., Dietze, R, Wages, J., Grogl, M., Berman, J. (1995). Diagnosis of symptomatic visceral leishmaniasis by use of the polymerase chain reaction on patient blood. J Infect Dis 171, 751-754.

Nwagwu, M., Opperdoes, F.R. (1982). Regulation of glycolysis in Trypanosoma brucei: hexokinase and phosphofructokinase activity. Acta Trop 39, 61-72.

O'Brien, J., Wilson, I., Orton, T., Pognan, F. (2000). Investigation of the Alamar Blue (resazurin) fluorescent dye for the ass€ssment of mammalian cell cytotoxicity. Eur J Biochem 267, 5421-5426. ~

Opperdoes, F.R, Borst, P. (1977). Localization of nine glycolytic enzymes in a microbody­like organelle in Trypanosoma brucei: the glycosome. FEBS Lett 80, 360-364.

Opperdoes, F.R (1984). Localization of the initial steps in alkoxyphospholipid biosynthesis in glycosomes (microbodies) of Trypanosoma brucei. FEBS Lett 169, 35-39.

Opperdoes, F.R, Baudhuin, P., Coppens, I., De Roe, C., Edwards, S.W., Weijers, P.J., Misset, O. (1984). Purification, morphometric analysis, and characterization of the

198

References

glycosomes (microbodies) of the protozoan hemoflagellate Trypanosoma brucei. J Cell BioI 98, 1178-1184.

Opperdoes, F.R. (1987). Compartmentation of carbohydrate metabolism in trypanosomes. Annu Rev Microbiol41, 127-151. V

Opperdoes, F.R., Michels, P.A. (2001). Enzymes of carbohydrate metabolism as potential drug targets. Int J Parasitol31, 482-490.V

Opperdoes, F.R., Coombs, G.H. (2007). Metabolism of Leishmania: proven and predicted. Trends Parasitol23, 149-158.~' /'

Ortega-Carnicer, J., Alcazar, R., D~la Torre, M., Benezet, J. (1997). Pentavalent antimonial-induced torsade de pointes. J Electrocardiol30, 143-145.

Otera, H., Harano, T., Honsho, M., Ghaedi, K., Mukai, S., Tanaka, A., Kawai, A., Shimizu, N., Fujiki, Y. (2000). The mammalian peroxin Pex5pL, the longer isoform of the mobile peroxisome targeting signal (PTS) type 1 transporter, translocates the Pex7p.PTS2 protein complex i~to ~oxisomes via its initial docking site, Pexl4p. J Bioi Chem 275, 21703-21714. \.../

Otera, H., Setoguchi, K., Hamasaki, M., Kumashiro, T., Shimizu, N., Fujiki, Y. (2002). Peroxisomal targeting signal receptor Pex5p interacts with cargoes and import machinery components in a spatiotemporally differentiated manner: conserved Pex5p WXXXFN motifs are critical for matrix protein import. Mol Cell Bioi 22, 1639-1655.~

Otzen, M., Wang, D., Lunenborg, M.G., van der Klei, I.J. (2005). Hansenula polymorpha Pex20p is an oligomer that binds the peroxisomal targeting signal 2 (PTS2). J Cell Sci 118, 3409-3418.

Ozaki, A., Katsumata, R., Oka, T., Furuya, A. (1984). Functional expression of the genes of Escherichia coli in gram-positive Corynebacterium glutamicum. Mol Gen Genet 196, 175-178.

Pabon, M.A., Caceres, A.J., Gualdron, M., Quinones, W., Avilan, L., Concepcion, J.L. (2007). Purification and characterization of hexokinase from Leishmania mexicana. Parasitol Res 100, 803-810.

Padgett, E.L., Pruett, S.B. (1992). Evaluation of nitrite production by human monocyte­derived macrophages. Biochem Biophys Res Commun 186, 775-781.

Page, B., Page, M., Noel, C. (1993 ). A new fluorometric assay for cytotoxicity measurements in vitro. Int J Oncol3, 473-476.

Page, R.D., Sambrook, M.A., Crossman, A.R. (1993). Thalamotomy for the alleviation of levodopa-induced dyskinesia: experimental studies in the I-methyl-4-phenyl-1 ,2,3,6-tetrahydropyridine-treated parkinsonian monkey. Neuroscience 55, 147-165.

Pai, K., Sodhi, A. (1991). Effect of cisplatin, rIFN-Y, LPS and MDP on release of H202, 02- and lysozyme from human monocytes in vitro. Indian J Exp Bioi 29, 910-915. \-----

Palatnik-de-Sousa, C.B., dos Santos, W.R., Franca-Silva, J.e., da Costa, R.T., Reis, A.B., Palatnik, M., Mayrink, W., Genaro, O. (2001). Impact of canine control on the epidemiology of canine and human visceral leishmaniasis in Brazil. Am J Trop Med Hyg 65,510-517.

Pal it, A., Kishore, K., Kesari, S., Kumar, V., Dinesh, D.S., Kar, S.K. (1996). Vector control methods of Leishmaniasis in India. In: Indian kala-azar (ed Sundar, S.). Kala-azar Medical Research Centre, Deptt. of Med., Instt. of Medical Sciences, Banaras Hindu University, Varanasi.

Palmer, R.M., Rees, D.D., Ashton, D.S., Moncada, S. (1988). L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 153, 1251-1256. V

199

References

Paul, K.S., Jiang, D., Morita, Y.S., Englund, P.T. (2001). Fatty acid synthesis in African trypanosomes: a solution to the myristate mystery. Trends Parasitol17, 381-387. '-..--­

Pepin, J., Milord, F. (1994). The treatment of human African trypanosomiasis. Adv Paras ito I 33, 1-47.

Peters, W., Trotter, E.R., Robinson, B.L. (1980). The experimental chemotherapy of leishmaniasis, V. The activity of potentialleishmanicides against 'L. infantum LV9' in NMRI mice. Ann Trop Med Parasitol74, 289-297.

Peters, W., Evans, D.A., Lanham, S.M. (1983). Importance of parasite identification in cases of leishmaniasis. J R Soc Med 76, 540-542. ~

Peters, W., Prasad, L.S.N. (1983). Kala-azar in India. Its importance as an issue in public health. In Proc. Indo-UK Workshop Leishmaniasis pp 3 ~

PfaIler, M.A., Buschelman, B., Bale, MJ., Lancaster, M., Espinel-Ingroff, A., Rex, lH., Rinaldi, M.G. (1994). Multicenter comparison of a colorimetric microdilution broth method with the reference macrodilution method for in vitro susceptibility testing of yeast isolates. Diagn Microbiol Infect Dis 19, 9-13.

Phelouzat, M.A., Lawrence, F., Robert-Gero, M. (1993). Characterization of sinefungin­resistant Leishmania donovani promastigotes. Parasitol Res 79, 683-689.

Philip, R., Epstein, L.B. (1986). Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-l. Nature 323,86-89.

Pires, J.R., Hong, X., Brockmann, C., Volkmer-Engert, R., Schneider-Mergener, J., Oschkinat, H., Erdmann, R. (2003). The ScPex13p SH3 domain exposes two distinct binding sites for Pex5p and Pexl4p. J Mol Bioi 326, 1427-1435.

Plock, A., Sokolowska-Kohler, W., Presber, W. (2001). Application of flow cytometry and microscopical methods to characterize the effect of herbal drugs on Leishmania Spp. Exp Parasitol97, 141-153.

Pommier, Y., Pourquier, P., Fan, Y., Strumberg, D. (1998). Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. Biochim Biophys Acta 1400, 83-105.

Prasher, D.C., Eckenrode, V.K., Ward, W.W., Prendergast, F.G., Cormier, MJ. (1992). Primary structure of the Aequorea victoria green-fluorescent protein. Gene 111,229-233.

Pratt, D.M., David, lR. (1981). Monoclonal antibodies that distinguish between New World species of Leishmania. Nature 291,581-583.

Preston, P.M., Carter, R.L., Leuchars, E., Davies, AJ., Dumonde, D.C. (1972). Experimental cutaneous leishmaniasis. 3. Effects of thymectomy on the course of infection ofCBA mice with Leishmania tropica. Clin Exp Immunoll0, 337-357. \

Preston, P.M., Dumonde, D.C. (1976). Experimental cutaneous leishmaniasis. V. Protective immunity in subclinical and self-healing infection in the mouse. Clin Exp Immunol 23, 126-138. ~ .

Puig, 0., Caspary, F., Rigaut, G., Rutz, B., Bouveret, E., Bragado-Nilsson, E., Wilm, M., Seraphin, B. (2001). The tandem affinity purification (TAP) .meth~ a general procedure of protein complex purification. Methods 24, 218-229. ~

Purdue, P.E., Lazarow, P.B. (2001). Peroxisome biogenesis. Annu Rev Cell Dev Bioi 17, 701-752.

Racagni, G.E., Machado de Domenech, E.E. (1983). Characterization of Trypanosoma cruzi hexokinase. Mol Biochem Parasitol9, 181-188.

Raether, W., Seidenath, H., Loewe, H. (1978). Action of p-(4-amidino-phenoxy)­benzaldehyde-p-amidino-phenylhydrazone dihydrochloride on Leishmania donovani infections in the golden hamster. Ann Trop Med Paras ito I 72, 543-547.

200

References

Ralph, P., Nakoinz, I. (1987). Stimulation of macrophage tumoricidal activity by the growth and differentiation factor CSF-I. Cell Immunoll05, 270-279.

Rashid, J.R., Chunge, C.N., Oster, C.N., Wasunna, K.M., Muigai, R., Gachihi, G.S. (1986). Post-kala-azar dermal leishmaniasis occurring long after cure of visceral leishmaniasis in Kenya. East Afr Med J 63, 365-371.

Raz, B., Iten, M., Grether-Buhler, Y., Kaminsky, R., Brun, R. (1997). The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro. Acta Trop 68, 139-147.

Reed, C.E. (1981). Allergic agents. Bull N Y Acad Med 57,897-906. Reed, S.G., Badaro, R., Lloyd, R.M. (1987). Identification of specific and cross-reactive

antigens of Leishmania donovani chagasi by human infection sera. J Immunol 138, 1596-1601.

Reed, S.G. (1988). In vivo administration of recombinant lPN-gamma induces macrophage' activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections. J Immuno/140, 4342-4347.

Rees, P.N., Kagar, P.A. (1987). Visceral leishmaniasis and post kala-azar dermal leishmaniasis. In the leishmaniasis in Biology and Medicine Vol 1 Clinical aspects and control. Edited by W. Peter and R. Killick-Kendrick Academic Press, U. K.,563.

Reiner, N.E. (1982). Host-parasite relationship in murine leishmaniasis: pathophysiological and immunological changes. Infect Immun 38, 1223-1230.

Reiner, S.L., Locksley, R.M. (1995). The regulation of immunity to Leishmania major. Annu Rev Immuno/13, 151-177.

Reithinger, R., Davies, c.R. (2002). Canine leishmaniasis: novel strategies for control. Trends Parasito/18, 289-290.

Repine, J.E., Fox, R.B., Berger, E.M. (1981). Hydrogen peroxide kills Staphylococcus aureus by reacting with staphylococcal iron to form hydroxyl radical. J Bioi Chern 256, 7094-7096.

Reyburn, H., Ashford, R., Mohsen, M., Hewitt, S., Rowland, M. (2000). A randomized controlled trial of insecticide-treated bednets and chaddars or top sheets, and residual spraying of interior rooms for the prevention of cutaneous leishmaniasis in Kabul, Afghanistan. Trans R Soc Trop Med Hyg 94, 361-366.

Rezai, H.R., Ardehali, S.M., Amirhakimi, G., Kharazmi, A. (1978). Immunological features ofkala-azar. Am J Trop Med Hyg27, 1079-1083.

Rijal, S., Chappuis, F., Singh, R., Boelaert, M., Loutan, L., Koirala, S. (2003). Sodium stibogluconate cardiotoxicity and safety of generics. Trans R Soc Trop Med Hyg 97, 597-598.

Rioux, J.A., Golvan, YJ., Croset, H., Houin, R. (1969). [Leishmanioses in the Mediterranean "Midi": results of an ecologic survey]. Bull Soc Pathol Exot Filiales 62,332-333.

Rioux, J.A., Dereure, J., Khiami, A., Pratlong, F., Sirdar, K., Lambert, M. (1990). [Ecoepidemiology of leishmaniasis in Syria. 1. Leishmania major Yakimoff and Schokhor (Kinetoplastida-Trypanosomatidae) infestation of Psammomys obesus Cretzschmar (Rodentia-Gerbillidae)]. Ann Parasitol Hum Comp 65, 203-207.

Ritmeijer, K., Davies, c., van Zorge, R., Wang, S.J., Schorscher, 1., Dongu'du, S.I., Davidson, R.N. (2007). Evaluation of a mass distribution programme for fine-mesh impregnated bednets against visceral leishmaniasis in eastern Sudan. Trop Med Int Health 12,404-414.

Robinson, D.R., Gull, K. (1991). Basal body movements as a mechanism for mitochondrial genome segregation in the trypanosome cell cycle. Nature 352, 731-733. v---

201

References

Rocha, L.G., Almeida, J.R, Macedo, RO., Barbosa-Filho, J.M. (2005). A review of natural products with antileishmanial activity. Phytomedicine 12, 514-535.

Rogers, M.E., Chance, M.L., Bates, P.A. (2002). The role of promastigote secretory gel in the origin and transmission of the infective stage of Leishmania mexicana by the sandfly Lutzomyia longipalpis. Parasitology 124, 495-507.

Rosano, C., Sabini, E., Rizzi, M., Deriu, D., Murshudov, G., Bianchi, M., Serafini, G., Magnani, M., Bolognesi, M. (1999). Binding of non-catalytic A TP to human hexokinase I highlights the structural components for enzyme-membrane association control. Structure 7, 1427-1437.

Rosypal, A.C., Troy, G.c., Zajac, A.M., Duncan, RB., Jr., Waki, K., Chang, K.P., Lindsay, D.S. (2003). Emergence of zoonotic canine leishmaniasis in the United States: isolation and immunohistochemical detection of Leishmania infantum from foxhounds from Virginia. J Eukaryot Microbiol50 SuppJ, 691-693.

Rosypal, A.C., Hall, J.E., Bakunova, S., Patrick, D.A., Bakunov, S., Stephens, C.E., Kumar, A., Boykin, D.W., Tidwell, RR (2007). In vitro activity of dicationic compounds against a North American foxhound isolate of Leishmania infantum. Vet Parasitol 145,207-216. V

Roy, G., Dumas, C., Sereno, D., Wu, Y., Singh, A.K., Tremblay, M.J., Ouellette, M., Olivier, M., Papadopoulou, B. (2000). Episomal and stable expression of the luciferase reporter gene for quantifying Leishmania spp. infections in macrophages and in animal models. Mol Biochem ParasitolllO, 195-206.

Rudolph, R, Neal, G.E., Williams, J.S., McMahan, A.P. (1995). Snakebite treatment at a southeastern regional referral center. Am Surg 61, 767-772.

Ryan, L., Vexenat, A., Marsden, P.D., Lainson, R, Shaw, J.J. (1990). The importance of rapid diagnosis of new cases of cutaneous leishmaniasis in pin-pointing the sandfly vector. Trans R Soc Trop Med Hyg 84, 786.

Sacks, D., Kamhawi, S. (2001). Molecular aspects of parasite-vector and vector-host interactions in leishmaniasis. Annu Rev Microbiol55, 453-483.

Sacks, D.L., Lal, S.L., Shrivastava, S.N., Blackwell, J., Neva, F.A. (1987). An analysis ofT cell responsiveness in Indian kala-azar. J Immunol138, 908-913.

Sadlova, J., Hajmova, M., Volf, P. (2003). Phlebotomus (Adlerius) halepensis vector competence for Leishmania major and Le. tropica. Med Vet Entomol17, 244-250. \..

Sah, J.F., Ito, H., Kolli, B.K., Peterson, D.A., Sassa, S., Chang, K.P. (2002). Genetic rescue of Leishmania deficiency in porphyrin biosynthesis creates mutants suitable for analysis of cellular events in uroporphyria and for photodynamic therapy. J Bio! Chem 277, 14902-14909.

Saba, B., Das, G., Vohra, H., Ganguly, N.K., Mishra, G.C. (1995). Macrophage-T cell interaction in experimental visceral leishmaniasis: failure to express costimulatory molecules on Leishmania-infected macrophages and its implication.> the suppression of cell-mediated immunity. Eur J Immuno!25, 2492-2498. V-

Sahasrabuddhe, A.A., Bajpai, V.K., Gupta, C.M. (2004). A novel form of actin in Leishmania: molecular characterisation, subcellular localisation and association with subpellicular microtubules. Mol Biochem Parasitol134, 105-114. ~

Saidowsky, J., Dodt, G., Kirchberg, K., Wegner, A., Nastainczyk, W., Kunau, W.H., Schliebs, W. (2001). The di-aromatic pentapeptide repeats of the human peroxisome import receptor PEX5 are separate high affinity binding sites for the peroxisomal membrane protein PEX14. J Bio! Chem 276, 34524-34529.

Saito, K., Suter, E. (1965). Lysosomal Acid Hydrolases and Hyperreactivity to Endotoxin in Mice Infected with Bcg. J Exp Med 121, 739-749. ~._

202

References

Salmanpour, R., Handjani, F., Nouhpisheh, M.K. (2001). Comparative study of the efficacy of oral ketoconazole with intra-Iesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis. J Dermatolog Treat 12, 159-162.

Salotra, P., Duncan, R.C., Singh, R, Subba Raju, B.V., Sreenivas, G., Nakhasi, H.L. (2006). Upregulation of surface proteins in Leishmania donovani isolated from patients of post kala-azar dermal leishmaniasis. Microbes Infect 8,637-644.

Salzman, T.A., Stella, A.M., Wider de Xifra, E.A., Batlle, A.M., Docampo, R, Stoppani, A.O. (1982). Porphyrin biosynthesis in parasitic hemoflagellates: functional and defective enzymes in Trypanosoma cruzi. Comp Biochem Physiol B 72,663-667.

Salzman, T.A., Batlle, A.M., Angluster, J., de Souza, W. (1985). Heme synthesis in Crithidia deanei: influence of the endosymbiote. Int J Biochem 17, 1343-1347.

Sampaio, S.A., Godoy, J.T., Paiva, L., Dillon, N.L., da, L.C. (1960). The treatment of American (mucocutaneous) leishmaniasis with amphotericin B. Arch Dermatol 82, 627-635.

Samuelson, J., Lerner, E., Tesh, R, Titus, R (1991). A mouse model of Leishmania braziliensis braziliensis infection produced by coinjection with sand fly saliva. J Exp Med 173, 49-54.

Sanyal, RK., Banerjee, D.P., Ghosh, T.K., Ghosh, J.N., Misra, B.S., Roy, V.P., Rao, C.K. (1979). A longitudinal review ofKala-azar in Bihar. J. Comm. Dis. 11, 149.

Schaeffer, W.I., Friend, K. (1976). Efficient detection of soft agar grown colonies using a tetrazolium salt. Cancer Lett 1, 259-262. '--

Scharton, T.M., Scott, P. (1993). Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med 178,567-577.

Schmidt, A., Krauth-Siegel, RL. (2002). Enzymes of the trypanothione metabolism as targets for antitrypanosomal drug development. Current Topics Med Chem 2, 1239-1259.

Schmidt, H., Peter, F.M. (1938). Advances in the therapeutics of antimony. Georg Thieme: Leipzig, Germany

Schneemann, M., Schoedon, G., Hofer, S., Blau, N., Guerrero, L., Schaffner, A. (1993). Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J Infect Dis 167, 1358-1363.

Schreiber, A.D., Kelley, M., Dziarski, A., Levinson, A.I. (1983). Human monocyte functional heterogeneity: monocyte fractionation by discontinuous albumin gradient centrifugation. Immunology 49,231-238.

Scott, P., Natovitz, P., Coffman, RL., Pearce, E., Sher, A. (1988). Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J Exp Med 168, 1675-1684.

Scott, P. (1991). Host and parasite factors regulating the development of CD4+ T-cell subsets in experimental cutaneous leishmaniasis. Res Immunol142, 32-36.

Scudiero, D.A., Shoemaker, RH., Paull, K.D., Monks, A., Tierney, S., Nofziger, T.R., Currens, M.J., Seniff, D., Boyd, M.R (1988). Evaluation of a soluble tetrazoliumlformazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48, 4827-4833.

Seeber, F., Boothroyd, J.C. (1996). Escherichia coli beta-galactosidase as an in vitro and in vivo reporter enzyme and stable transfection marker in the intracellular protozoan parasite Toxoplasma gondii. Gene 169,39-45.

203

References

Seifert, K., Matu, S., Javier Perez-Victoria, F., Castanys, S., Gamarro, F., Croft, S.L. (2003). Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine). Int J Antimicrob Agents 22, 380-387.

Sen Gupta, P.C. (1944). Indian Med Gazz 79, 50. Cited from steck, E. A., in the leishmaniasis. Prog Drug Res 18,283.

Sereno, D., Lemesre, J.L. (1997). Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents. Antimicrob Agents Chemother 41, 972-976.

Sereno, D., Holzmuller, P., Lemesre, J.L. (2000). Efficacy of second line drugs on antimonyl-resistant amastigotes of Leishmania infantum. Acta Trop 74,25-31.

Sereno, D., Holzmuller, P., Mangot, I., Cuny, G., Ouaissi, A., Lemesre, J.L. (2001a). Antimonial-mediated DNA fragmentation in Leishmania infantum amastigotes. Antimicrob Agents Chemother 45,2064-2069.

Sereno, D., Roy, G., Lemesre, J.L., Papadopoulou, B., Ouellette, M. (2001b). DNA transformation of Leishmania infantum axenic amastigotes and their use in drug screening. Antimicrob Agents Chemother 45, 1168-1173.

Seth, P., Alrajhi, A.A., Kagevi, I., Chaudhary, M.A., Colcol, E., Sahovic, E., Aljurf, M., Gyger, M. (2002). Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graft-versus-host disease. Bone Marrow Transplant 30, 189-194.

Shahan, T.A., Siegel, P.D., Sorenson, W.G., Kuschner, W.G., Lewis, D.M. (1994). A sensitive new bioassay for tumor necrosis factor. J Immunol Methods 175, 181-187.

Sharma, N.L., Mahajan, V.K., Kanga, A., Sood, A., Katoch, V.M., Mauricio, I., Singh, C.D., Parwan, U.C., Sharma, V.K., Sharma, RC. (2005). Localized cutaneous leishmaniasis due to Leishmania donovani and Leishmania tropica: preliminary findings of the study of 161 new cases from a new endemic focus in himachal pradesh, India. Am J Trop Med Hyg 72, 819-824.

Sherwood, J.A., Gachihi, G.S., Muigai, RK., Skillman, D.R, Mugo, M., Rashid, J.R, Wasunna, K.M., Were, J.B., Kasili, S.K., Mbugua, J.M., et al. (1994). Phase 2 efficacy trial of an oral 8-aminoquinoline (WR6026) for treatment of visceral leishmaniasis. Clin Infect Dis 19, 1034-1039.

Shi, H., Djikeng, A., Mark, T., Wirtz, E., Tschudi, c., Ullu, E. (2000). Genetic interference in Trypanosoma bruc,ei, by heritable and inducible double-stranded RNA. Rna 6, 1069-1076. ~

Shih, S., Hwang, H.Y., Carter, D., Stenberg, P., Ullman, B. (1998). Localization and targeting of the Leishmania donovani hypoxanthine-guanine phosphoribosyltransferase to the glycosome. J Bioi Chem 273, 1534-1541.

Shivaramakrishnamaiah, K., Ramanathan, R (1967). Studies on the effect of climate on leishmaniasis in India. Ind. J Med. Res. 55, 1159.

Sichting, M., Schell-Steven, A., Prokisch, H., Erdmann, R., Rottensteiner, H. (2003). Pex7p and Pex20p of Neurospora crassa function together in PTS2-dependent protein import into peroxisomes. Mol Bioi Cell 14, 810-821. ~

Silamut, K., White, N.J., Looareesuwan, S., Warrell, D.A. (1985). Binding of quinine to plasma proteins in falciparum malaria. Am J Trop Med Hyg 34, 681-686.

Singh, N., Dube, A. (2004). Short report: fluorescent Leishmania: application to anti­leishmanial drug testing. Am J Trop Med Hyg 71, 400-402. L/

Singh, R, Das, RK., Sharma, S.K. (2001). Resistance of sandflies to DDT in Kala-azar endemic districts of Bihar, India. Bull World Health Organ 79, 793. I .

v'

204

References

Singh, S.P~, Reddy, D.C., Rai, M., Sundar, S. (2006). Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India. Trop Med Int Health 11, 899-905. V

Smith, A.C., Yardley, V., Rhodes, J., Croft, S.L. (2000). Activity of the novel immunomodulatory compound tucaresol against experimental visceral leishmaniasis. Antimicrob Agents Chemother 44, 1494-1498.

Solbach, W., Laskay, T. (2000). The host response to Leishmania infection. Adv Immunol 74,275-317.

Soto, J., ·Buffet, P., ~GrOgl' M .. Berman, J. (1994). Successful treatment of Colombian cutaneous leishm . IS with four injections of pentamidine. Am J Trop Med Hyg 50,107-111.

Soto, J., Toledo, J.T. (2007). Oral miltefosine to treat new world cutaneous leishmaniasis. Lancet Infect Dis 7, 7.

Spath, G.F., Epstein, L., Leader, B., Singer, S.M., Avila, H.A., Turco, S.J., Beverley, S.M. (2000). Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major. Proc Nat! Acad Sci US A 97, 9258-9263.

Spath, G.F., Garraway, L.A., Turco, SJ., Beverley, S.M. (2003). The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts. Proc Natl Acad Sci USA 100, 9536-9541.

Spiegel, S., Milstien, S. (2002). Sphingosine I-phosphate, a key cell signaling molecule. J Bioi Chem 277, 25851-25854.

Squires, K.E., Schreiber, R.D., McElrath, MJ., Rubin, B.Y., Anderson, S.L., Murray, H.W. (1989). Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response. J Immuno/143, 4244-4249.

Stauber, L.A., Franchino, E.M., Grun, J. (1958). An eight day method for screening of compounds against Leishmania donovani in the golden hamster. J Protozoo/5, 269.

Stauber, L.A. (1963). Immunity to Leishmania. Ann N Y Acad Sci 113, 409-417. Steff, A.M., Fortin, M., Arguin, C., Hugo, P. (2001). Detection of a decrease in green

fluorescent protein fluorescence for the monitoring of cell death: an assay amenable to high-throughput screening technologies. Cytometry 45,237-243.

Steiger, R.F., Steiger, E. (1976). A defined medium for CUltivating Leishmania donovani and L. braziliensis. J Parasitol 62, 1010-1011.

Stein, K., Schell-Steven, A., Erdmann, R., Rottensteiner, H. (2002). Interactions of Pex7p and Pexl8p/Pex21p with the peroxisomal docking machinery: implications for the first steps in PTS2 protein import. Mol Cell Bioi 22, 6056-6069. ~

Stenger, S., Thuring, H., Rollinghoff, M., Bogdan, C. (1994). Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J Exp Med 180, 783-793.

Stewart, L., Redinbo, M.R., Qiu, X., HoI, W.G., Champoux, J.J. (1998). A model for the mechanism of human topoisomerase I. Science 279, 1534-1541.

Subramani, S. (1998). Components involved in peroxisome import, biogenesis, proliferation, turnover, and movement. Physiol Rev 78, 171-188.

Sudhandiran, G., Shaha, C. (2003). Antimonial-induced increase in intracellular Ca2+ through non-selective cation channels in the host and the parasite is responsible for apoptosis of intracellular Leishmania donovani amastigotes. J Bioi Chem 278, 25120-25132.

Sundar, S., Singh, V.P., Agrawal, N.K., Gibbs, D.L., Murray, H.lV. (1996). Treatment of kala-azar with oral fluconazole. Lancet 348, 614. V"

205

References

Sundar, S., Reed, S.G., Sharma, S., Mehrotra, A., Murray, H.W. (1997). Circulating T helper 1 (Th 1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis. Am J Trop Med Hyg 56, 522-525. '

Sundar, S., Sinha, P.R, Agrawal, N.K, Srivastava, R, Rainey, P.M., Berman, J.D., Murray, H.W., Singh, V.P. (1998). A cluster of cases of severe cardiotoxicity among kala­azar patients treated with a high-osmolarity lot of sodium antimony gluconate. Am J TropMedHyg59, 139-143. ~/'

Sundar, S. (2001). Drug.resistance in Indian visceral leishmaniasis. Trop Med Int Health 6, 849-854. ~

Sundar, S., Jha, T.K, Thakur, C.P., Engel, J., Sindermann, H., Fischer, c., Junge, K, Bryceson, A., Berman, J. (2002a). Oralmiltefosine for Indian visceral leishmaniasis. N Engl J Med 347, 1739-1746. ~/

Sundar, S., Jha, T.K, Thakur, C.P., Mishra, M., Singh, V.R, Buffels, R (2002b). Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study. Am J Trop Med Hyg 66, 143-146.

Sundar, S., Rai, M. (2002). ~ances in the treatment of leishmaniasis. Curr Opin Infect Dis 15, 593-598. t...--"

Sundar, S., Jha, T.K, Thakur, C.P., Mishra, M., Singh, V.P., Buffels, R. (2003). Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study. Clin Infect Dis 37, 800-804. ~.

Sundar, S., Mehta, H., Suresh, A.V., Singh, S.P., Rai, M., Murray, H.W. (2004). Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clin Infect Dis 38, 377-383. ~.

Sundar, S., Murray, H.W. (2005). Availability of miltefosine for the treatment of kala-azar in India. Bull World Health Organ 83, 394-395. "---

Sundar, S., Jha, T.K., Thakur, C.P., Bhattacharya, S.K, Rai, M. (2006). Oral miltefosine for the treatment of Indian visceral leishmaniasis. Trans R Soc Trop Med Hyg 100 Suppll, S26-33. V

Sundar, S., Jha, T.K, Thakur, C.P., Sinha, P.K, Bhattacharya, S.K (2007). Injectable paromomycin for Visceral leishmaniasis in India. N Engl J Med 356,2571-2581. L-

Surolia, N., Surolia, A. (2001). Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum. Nat Med 7, 167-173.

Sylvester, D., Krassner, S.M. (1976). Proline metabolism in Trypanosoma cruzi epimastigotes. Comp Biochem Physiol B 55, 443-447.

TDRNews (2005). Applying genomics to drug discovery research. 74,2. Teklemariam, S., Hiwot, A.G., Frommel, D., Miko, T.L., Ganlov, G., Bryceson, A. (1994).

Aminosidine and its combination with sodium stibogluconate in the treatment of diffuse cutaneous leishmaniasis caused by Leishmania aethiopica. Trans R Soc Trop Med Hyg 88,334-339.

Tenover, F.e., Swenson, J.M., O'Hara, C.M., Stocker, S.A. (1995). Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci. J Clin Microbiol33, 1524-1527.

Tesh, RB. (1995). Control of zoonotic visceral leishmaniasis: is it time to change strategies? Am J Trop Med Hyg 52,287-292.

Tetley, L., Vickerman, K (1991). The glycosomes of trypanosomes: number and distribution as revealed by electron spectroscopic imaging and 3-D reconstruction. J Microsc 162, 83-90.

Teusink, B., Diderich, J.A., Westerhoff, H.V., van Dam, K, Walsh, M.C. (1998). Intracellular glucose concentration in derepressed yeast cells consuming glucose is high enough to reduce the glucose transport rate by 50%. J Bacteriol180, 556-562.

206

References

Tewari, N., Mishra, R.C., Tiwari, V.K., Tripathi, RP. (2002). Synlett 11, 1779-1782. Thakur, C.P., Kumar, M., Kumar, P., Mishra, B.N., Pandey, A.K. (1988). Rationalisation of

regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised study. Br Med J (Clin Res Ed) 296,1557-1561. l,

Thakur, C.P., Kumar, K. (1990). Efficacy of prolonged therapy with stibogluconate in post kala-azar dermal leishmaniasis. Indian J Med Res 91, 144-148. L

Thakur, C.P., Sinha, G.P., Pandey, A.K., Barat, D., Sinha, P.K. (1993). Amphotericin B in resistant kala-azar in Bihar. Natl Med J India 6, 57-60. ~

Thakur, C.P. (1998). Sodium antimony gluconate, amphotericin, and myocardial damage. Lancet 351, 1928-1929. ~-

Thakur, C.P., Kumar, P., Kumar, N., Singh, G.N., Singh, A.K., Narain, S. (1998). A randomized comparison of classical mode of administration of amphotericin B with its newer modes of administration in kala-azar. J Assoc Physicians India 46, 779-· 783.\.---

Thakur, C.P., Singh, RK., Hassan, S.M., Kumar, R, Narain, S., Kumar, A. (1999). Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases. Trans R Soc Trop Med Hyg 93,319-323. l,..---

Thakur, C.P., Kanyok, T.P., Pandey, A.K., Sinha, G.P., Messick, C., o lliaro , P. (2000). Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study. Trans R Soc Trop Med Hyg 94,432-433. L--

Thakur, C.P., Dedet, J.P., Narain, S., Pratlong, F. (2001). Leishmania species, drug unresponsiveness am{visceralleishmaniasis in Bihar, India. Trans R Soc Trop Med Hyg95, 187-189. V

Then, RL., Hartman, P.G., Kompis, I., Santi, D. (1993). Selective inhibition of dihydrofolate reductase from problem human pathogens. Adv Exp Med Bioi 338, 533-536.

Theodoropoulos, G., Theis, J.H. (1989). Decrease of acid phosphatase activity in murine peritoneal macrophages infected with Leishmania donovani. Int J Parasitol19, 813-816.'',..

Theoharides, A.D., Chung, H., Velazquez, H. (1985). Metabolism of a potential 8-aminoquinoline antileishmanial drug in rat liver microsomes. Biochem Pharmacol ,. 34, 181-188. ~~

Thevelein, J.M., Hohmann, S. (1995). Trehalose synthase: guard to the gate of glycolysis in yeast? Trends Biochem Sci 20, 3-10.

Titus, RG., Kelso, A., Louis, J.A. (1984). Intracellular destruction of Leishmania tropica by macrophages activated with macrophage activating factor/interferon. Clin Exp ImmunoI55,157-165.

Titus, RG., Sherry, B., Cerami, A. (1989). Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. J Exp Med 170, 2097-2104. L.---

Tracey, K.J., Wei, H., Manogue, K.R, Fong, Y., Hesse, D.G., Nguyen, H.T., Kuo, G.C., Beutler, B., Cotran, RS., Cerami, A., et al. (1988). Cachectinltumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med 167, 1211-1227.

Travi, B.L., Osorio, Y., Melby, P.C., Chandrasekar, B., Arteaga, L., Saravia, N.G. (2002). Gender is a major determinant of the clinical evolution and immune response in hamsters infected with Leishmania spp. Infect Immun 70, 2288-2296.

Trotter, E.R, Peters, W., Robinson, B.L. (1980). The experimental chemotherapy of leishmaniasis, IV. The development of a rodent model for visceral infection. Ann Trop Med Parasito/74, 127-138.

207

References

Tsien, RY. (1998). The green fluorescent protein. Annu Rev Biochem 67,509-544. Turk, J.L., Bryceson, A.D. (1971). Immunological phenomena in leprosy and related

diseases. Adv Immunol13, 209-266. Ullu, E., Tschudi, c., Chakraborty, T. (2004). RNA interference in protozoan parasites. Cell

MicrobioI6,509-519. Umasankar, P.K., Jayakumar, P.C., Shouche, Y.S., Patole, M.S. (2005). Molecular

characterization of the hexokinase gene from Leishmania major. J Parasitol 91, 1504-1509.

Urbina, J.A. (1997). Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites. Parasitology 114 Suppl, S91-99.

Urquhart, AJ., Kennedy, D., Gould, S.J., Crane, D.1. (2000). Interaction of Pex5p, the type I peroxisome targeting signal receptor, with the peroxisomal membrane proteins Pexl4p and Pex13p. J Bioi Chem 275, 4127-4136.

Valdivia, RH., Falkow, S. (1997). Probing bacterial gene expression within host cells. Trends Microbiol5, 360-363.

Van Hellemond, J.1., Tielens, A.G. (1997). Inhibition of the respiratory chain results in a reversible metabolic arrest in Leishmania promastigotes. Mol Biochem Parasitol 85, 135-138.

van Meer, G., Lisman, Q. (2002). Sphingolipid Transport; Rafts and Translocators. Journal o/biological chemistry, Papers in Press.

Varesio, L. (1984). Down regulation of RNA labeling as a selective marker for cytotoxic but not suppressor macrophages. J Immunol132, 2683-2685.

Varesio, L., Blasi, E., Thurman, G.B., Talmadge, J.E., Wiltrout, R.H., Herberman, R.B. (1984). Potent activation of mouse macrophages by recombinant interferon-gamma. Cancer Res 44, 4465-4469.

Veeken, H., Ritmeijer, K. (2006). [Leishmaniasis: progress in diagnosis, treatment and prevention]. Ned Tijdschr Geneeskd 150,2686-2688. V--

Vercesi, A.E., Docampo, R (1992). Ca2+ transport by digitonin-permeabilized Leishmania donovani. Effects of Ca2+, pentamidine and WR-6026 on mitochondrial membrane potential in situ. Biochem J 284 ( Pt 2), 463-467.

Visser, N., Opperdoes, F.R., Borst, P. (1981). Subcellular compartmentation of glycolytic intermediates in Trypanosoma brucei. Eur J Biochem 118, 521-526.

Volf, P., Killick-Kendrick, R, Bates, P.A, Molyneux, D.H. (1994). Comparison of the haemagglutination activities in gut and head extracts of various species and geographical populations of phlebotomine sandflies. Ann Trop Med Parasitol 88, 337-340.

Voytik-Harbin, S.L., Brightman, AO., Waisner, B., Lamar, C.H., Badylak, S.F. (1998). Application and evaluation of the alamarBlue assay for cell growth and survival of fibroblasts. In vitro Cell Dev Bioi Anim 34, 239-246.

Wahinya, D.N., Mbati, P.A, Jomo, P.M., Githure, J.1. (1998). Relationship between parasite load and immune responses in early stages of Leishmania donovani infection in inbred BALB/c mice. East Afr Med J75, 156-159.

Waller, R.F., Keeling, PJ., Donald, RG., Striepen, B., Handman, E., Lang-Unnasch, N., Cowman, A.F., Besra, G.S., Roos, D.S., McFadden, G.I. (1998). Nuclear-encoded proteins target to the plastid in Toxoplas~a g~and Plasmodium falciparum. Proc Nat! Acad Sci USA 95, 12352-12357. ~

Wang, Z.E., Zheng, S., Corry, D.B., Dalton, D.K., Seder, R.A., Reiner, S.L., Locksley, RM. (1994). Interferon gamma-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proc Natl Acad Sci U SA 91, 12932-12936.

208

References

Warner, L., Newman, D.R, Austin, H.D., Kamb, M.L., Douglas, J.M., Jr., Malotte, C.K., Zenilman, J.M., Rogers, J., Bolan, G., Fishbein, M., Kleinbaum, D.G., Macaluso, M., Peterman, T.A. (2004). Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the ~rtance of assessing partner infection status. Am J Epidemiol159, 242-251. V .

Wasunna, M.K., Rashid, J.R, Mbui, J., Kirigi, G., Kinoti, D., Lodenyo, H., Felton, J.M., Sabin, A.J., Albert, M.J., Horton, J. (2005). A phase II dose-increasing study of sitamaquine for the treatment of visceral leishmaniasis in Kenya. Am J Trop Med Hyg 73,871-876.

Webb, J.R, Kaufmann, D., Campos-Neto, A., Reed, S.G. (1996). Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis. J Immunol157, 5034-5041.

Wei, X.Q., Charles, I.G., Smith, A., Ure, J., Feng, GJ., Huang, F.P., Xu, D., Muller, W., Moncada, S., Liew, F.Y. (1995). Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375, 408-411.

Weiser, W.Y., Van Niel, A., Clark, S.c., David, J.R, Remold, H.G. (1987). Recombinant human granulocyte/macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages. J Exp Med 166, 1436-1446.

Welsh, S., Kay, S.A. (1997). Reporter gene expression for monitoring gene transfer. Curr Opin Biotechnol8, 617-622.

White, M.J., DiCaprio, M.J., Greenberg, D.A. (1996). Assessment of neuronal viability with Alamar blue in cortical and granule cell cultures. J Neurosci Methods 70, 195-200.

WHO (1990). Control of the Leishmaniasis. Technical report series 793. WHO (2002). The world health report 2002 - Reducing Risks, Promoting Healthy Life.

World Health Organization, Geneva. WHO (2005). Make every mother and child count. World Health Organization, Geneva. Willson, M., Sanejouand, Y.H., Perie, J., Hannaert, V., Opperdoes, F. (2002). Sequencing,

modeling, and selective inhibition of Trypanosoma brucei hexokinase. Chern Bioi 9, 839-847.

Wilson, J.E. (1997). Homologous and heterologous interactions between hexokinase and mitochondrial porin: evolutionary implications. J Bioenerg Biomembr 29,97-102. L

Wilson, M.E., Young, B.M., Andersen, K.P., Weinstock, J.V., Metwali, A., Ali, K.M., Donelson, J.E. (1995). A recombinant Leishmania chagasi antigen that stimulates cellular immune responses in infected mice. Infect Immun 63, 2062-2069.

Wirth, D.F., Pratt, D.M. (1982). Rapid identification of Leishmania species by specific hybridization of kinetoplast DNA in cutaneous lesions. Proc Natl Acad Sci USA 79,6999-7003.

Woodward, A.W., Bartel, B. (2005). The Arabidopsis peroxisomal targeting signal type 2 receptor PEX7 is necessary for peroxisome function and dependent on PEX5. Mol Bioi Cell 16, 573-583.

Wyler, D.J., Weinbaum, F.I., Herrod, H.R (1979). Characterization of in vitro proliferative responses of human lymphocytes to leishmanial antigens. J Infect Dis 140, 215-221.

Yahia, H., Ready, P.D., Hamdani, A., Testa, J.M., Guessous-Idrissi, N. (2004). Regional genetic differentiation of Phlebotomus sergenti in three Moroccan foci of cutaneous leishmaniasis caused by Leishmania tropica. Parasite 11, 189-199.

Yeates, C. (2002). Sitamaquine (GlaxoSmithKlinelWalter Reed Army Institute). Curr Opin Investig Drugs 3, 1446-1452.

Zabransky, RJ., Dinuzzo, A.R, Woods, G.L. (1995). Detection of vancomycin resistance in enterococci by the Alamar MIC system. J Clin Microbiol 33, 791-793.

209

References

Zalata, AA., Lammertijn, N., Christophe, A, Comhaire, F.H. (1998). The correlates and alleged biochemical background of the resazurin reduction test in semen. Int J Androl21, 289-294.

Zarley, J.H., Britigan, B.E., Wilson, M.E. (1991). Hydrogen peroxide-mediated toxicity for Leishmania donovani chagasi promastigotes. Role of hydroxyl radical and protection by heat shock. J Clin Invest 88, 1511-1521.

Zhai, L., Chen, M., Blom, J., Theander, T.G., Christensen, S.B., Kharazmi, A (1999). The antileishmanial activity of novel oxygenated chalcones and their mechanism of action. J Antimicrob Chemother 43, 793-803.

Zhang, K., Hsu, F.F., Scott, D.A, Docampo, R, Turk, J., Beverley, S.M. (2005). Leishmania salvage and remodelling of host sphingolipids in amastigote survival andacidocalcisome biogenesis Mol Microbiol55, 1566-1578.

Zhang, W.W., Charest, H., Ghedin, E., Matlashewski, G. (1996). Identification and overexpression of the A2 amastigote-specific protein in Leishmania donovani. Mol Biochem Parasitol78, 79-90.

Zijlstra, E.E., Ali, M.S., el-Hassan, A.M., el-Toum, LA., Satti, M., Ghalib, H.W., Sondorp, E., Winkler, A. (1991). Kala-azar in displaced people from southern Sudan: epidemiological, clinical and therapeutic findings. Trans R Soc Trop Med Hyg 85, 365-369.

Zil'berman, M.N., Koromyslov, S.G. (1982). [Suprapubic paraurethropexy (modified Pereira operation) in urinary incontinence in women]. Akush Ginekol (Mosk), 16-18.

Zufferey, R, Allen, S., Barron, T., Sullivan, D.R, Denny, P.W., Almeida, LC., Smith, D.F., Turco, SJ., Ferguson, M.A, Beverley, S.M. (2003). Ether phospholipids and glycosylinositolphospholipids are not required for amastigote virulence or for inhibition of macrophage activation by Leishmania major. J Bioi Chem 278, 44708-44718. ( ,~ ..

v

210